Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Pacific

Pacific Current Group Limited

Premium
Information Technology

Pacific Current Group is an ASX-listed, multi-boutique "GP-stakes" investment company that historically acquired minority equity and revenue-share interests in independent asset managers — predominantly US-based alternative and private-markets firms — and supplied them with permanent capital, institutional distribution and operational support. Since 2023 the company has undergone a decisive transformation: after two contested control processes (Regal Partners in 2023, GQG Partners and River Capital in 2023–24), it monetised most of its portfolio (GQG, Proterra, Cordillera, Avante, Carlisle, Banner Oak, Pennybacker partial, Victory Park partial, Aether), returned A$265m to shareholders through an off-market buy-back, repaid all debt, and pivoted its earnings base toward contractual interest income from secured lending to its own boutiques. Today PAC is a small (~A$311m), debt-free, cash-rich holding company with seven residual boutique interests, a controlling-scale shareholder in River Capital (~43%), and a live strategic review contemplating a reverse-style acquisition, sale, or orderly wind-down. --- **Company's own description.** In its ASX boilerplate (FY26 announcements) PAC describes itself as a global multi-boutique asset management firm dedicated to providing exceptional value to shareholders, investors and partners, applying strategic resources — including capital, institutional distribution capabilities and operational expertise — to help its boutique partners excel. As of 27 August 2026 the company states it holds investments in seven boutique firms globally. **How the business works.** PAC is not itself a fund manager running client money; it is an owner of economic interests in other fund managers ("boutiques"). Those interests take several forms: 1. **Equity stakes / GP stakes** — minority ownership in the management company (and sometimes in the general partner entity that receives carried interest). 2. **Revenue shares** — contractual entitlements to a percentage of a boutique's management-fee revenue (top-line participation that is senior to boutique operating costs). 3. **Profit distributions** — dividends/distributions from equity interests. 4. **Performance fees and carried interest participation** — e.g., performance fees in FY26 came largely from Roc Partners (H1 FY26 presentation). 5. **Secured lending (new since FY26)** — first-ranking secured loans to boutiques or their affiliates at 10–11% p.a. (Roc affiliate A$2m; NLAA US$2.1m; IFP US$25.1m). 6. **Financial assets** — listed and unlisted securities received as sale consideration (Abacus Global Management shares and bonds received for Carlisle; Janus Henderson Group shares received for Victory Park, since sold), plus deferred consideration (e.g., Pennybacker sale to Petershill). **Revenue model mix (FY26 underlying, A$m, FY26 Results Presentation):** In FY26 interest income represented 67% of underlying income and covered corporate overheads 3.1 times. The business has therefore shifted from an "equity-participation" model toward a "yield-plus-optionality" model: contractual interest on cash and secured loans, plus residual (and more volatile) boutique distributions and performance fees. **Value-chain position.** PAC sits at the capital-provider layer of the asset-management value chain — between institutional/strategic capital and emerging or mid-sized independent managers. Its customers in a commercial sense are the boutiques themselves (which "buy" capital and services by granting PAC economics), while the boutiques' end clients are institutional investors (pensions, endowments, insurers, sovereign funds), wealth channels and, in IFP's case, independent financial advisers. Historically also agribusiness/natural resources private equity (Proterra), lending to lower-middle-market companies (Avante), life-settlements (Carlisle), real estate (Banner Oak), and natural-resource private equity (Aether). **Independent characterisation.** PAC today is best understood as a listed, closed-ended investment holding company in run-off/transition, not a growth asset-management platform. Its value is dominated by (a) A$158m cash, (b) roughly A$100m of other financial assets and secured loans, and (c) residual boutique stakes carried at a mix of fair value and cost. The share price (~A$11.14) trades at about 69% of management's fair-value NAV (A$16.18) and 80% of statutory NAV (A$13.96). The investment case is driven primarily by corporate-action outcomes (strategic review) rather than organic FUM growth.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2014
Sydney, Australia

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Advance

Advance Metals Limited

Premium
Information Technology

Advance Metals Limited is a pre-revenue ASX micro-cap explorer. Its legacy was coal and renewable-energy investments, and it now builds a high-grade silver-gold portfolio in Mexico's Sierra Madre Occidental belt with gold optionality in Victoria, Australia. The core asset is the 100%-owned Yoquivo Silver-Gold Project in Chihuahua, which carries an initial JORC (2012) Inferred Mineral Resource of 8.8Mt at 120 g/t AgEq for 33Moz AgEq (8 Apr 2026). It sits alongside the 100%-owned Gavilanes Silver Project in Durango, which management now calls its flagship, and an earn-in over Endeavour Silver's Guadalupe y Calvo gold-silver project. On paper these assets total 116Moz AgEq, but 83Moz of that is non-JORC "Foreign Estimates". The company also holds the Myrtleford and Beaufort gold projects in Victoria and is moving to 100% ownership. Management, led by MD/CEO Dr Adam McKinnon since January 2025, is targeting a 200Moz+ AgEq endowment. The company describes that target as aspirational, not an Exploration Target. The equity story rests on low-cost resource acquisition and conversion, while the balance sheet depends on continual equity raising. --- **What the company does.** Advance Metals is a mineral exploration company. It acquires under-explored or distressed-vendor precious-metals projects, typically ones with historical drilling and non-JORC "foreign" estimates. It then re-models, re-samples and drills them to produce JORC-compliant Mineral Resources, which it aims to advance towards development or monetise. It has no producing assets, no product sales and no customers in the commercial sense (FY2025 AR, Note 21: the Group "does not yet have any products or services from which it derives an income"). **Company's own description (paraphrased from FY2025 AR, Review of Operations).** The company says it is focused on discovering and developing high-grade precious-metal deposits in established mining jurisdictions in Mexico and Australia. Its strategy is to acquire and advance high-quality projects that could host significant gold and silver mineralisation capable of supporting long-term development. In FY2025 it built a diversified portfolio across the Sierra Madre Occidental belt and the Victorian Goldfields. **Independent characterisation.** In practice AVM works as a project aggregator and resource-conversion vehicle. Its demonstrated edge is low acquisition cost. For example, it bought Yoquivo for US$570,000 cash from a financially distressed Golden Minerals (Golden Minerals 10-K FY2024). It then converted the asset into a 33Moz AgEq JORC resource at a stated all-in cost of about US$0.10/oz AgEq (ASX 8 Apr 2026). The model is capital-light per project but cash-hungry in aggregate. Operating and investing outflows were about A$6.8M in FY2025, against near-zero income. Value creation therefore depends on resource growth outpacing dilution.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2001
Mount Hawthorn, Australia
WeedOUT

WeedOUT Ltd

Premium
Information Technology

WeedOUT is an Israeli agricultural biotechnology developer. Its product is a species-specific biological herbicide that works through reproduction, not through plant toxicity. The method borrows the logic of the sterile insect technique, which has been used against flies and mosquitoes since the 1940s. The company: - grows male plants of a target weed; - harvests their pollen; - sterilises the pollen by irradiation; - releases it over infested fields. The treated pollen fertilises female weed flowers but produces non-viable, aborted seed. This depletes the weed seedbank season after season. The first target is Palmer amaranth (*Amaranthus palmeri*), the most economically damaging herbicide-resistant weed in US cotton, soybean, corn and sugar beet. It is also a serious problem in Brazil and Argentina. WeedOUT positions the product as a complement to chemical programmes inside integrated weed management, not as a replacement. Its core value claim is that it attacks a complex reproductive process rather than a single enzyme pathway, which should make resistance harder to evolve. As of the latest public information, the company is pre-revenue and awaiting US EPA marketing approval. --- ### What the company does WeedOUT develops what it describes as the industry's first species-specific biological herbicide (AgFunder News, 2020). The production chain has four steps: 1. Male plants of the target weed species are grown in controlled net houses. Palmer amaranth produces fresh pollen daily (AgWeb). 2. The pollen is collected. 3. The pollen is irradiated so it is sterile but still able to fertilise. 4. Target weeds in the field are artificially pollinated with dispersing equipment, currently using a dry application (AgFunder 2020; AgWeb). According to the company, its pollen has two key properties: - it competes successfully against naturally occurring weed pollen; - it still fertilises the ovule (Future Farming, 2024). Co-founder Efrat Lidor Nili has told trade press that every seed formed after fertilisation with WeedOUT pollen is aborted (AgWeb). The company stresses that the pollen is exclusive to Palmer amaranth and does not affect row crops or other plants (AgWeb). ### Company's own description WeedOUT does not publish an annual report. In its February 2024 funding announcement, the company describes its technology as a novel, environmentally conscious way to sharply curb the spread of weeds that no longer respond to common chemical herbicides (Precision Farming Dealer, 2024). Startupim's owner-claimed profile adds three points: - the product is made with natural ingredients; - its aim is to reduce reliance on toxic herbicides and escalating doses; - it blocks the next generation of viable weed seeds through artificial pollination (Startupim raw profile). ### Independent characterisation WeedOUT is best described as a pre-commercial, single-asset biological crop-protection platform company. The platform claim rests on the idea that the sterile-pollen method can be repeated across other wind-pollinated, dioecious weeds. Palmer amaranth is a near-ideal first target for three reasons: - it is dioecious (separate male and female plants), so female flowers depend entirely on outside pollen; - it produces very large seed numbers per female plant, so cutting seed set has a compounding effect on the seedbank; - it has developed resistance to multiple herbicide modes of action. The company is also developing formulations for other weed species (Produce Processing, 2024). It intends to extend first to other *Amaranthus* weeds (AgWeb); waterhemp (*A. tuberculatus*) is the logical next candidate, though the company has not publicly named it. **Mode of action.** The product does not kill the treated plant. Management has acknowledged that a standing Palmer plant late in the season is probably already resistant. The treatment's job is to stop that plant from contributing viable seed (Farm Progress, 2020). The economic benefit is therefore multi-season seedbank reduction, not in-season yield protection. This has major consequences for how the product is sold, priced and demonstrated (see §10 and §22). ### Business and revenue model | Dimension | Characterisation | Basis | |---|---|---| | Revenue model | Expected product sales of treated pollen, possibly bundled with application services or equipment. No revenue disclosed. | Inferred from product description; no disclosure | | Product vs service vs subscription vs licensing mix | Not publicly disclosed. Caplight lists the business model as B2B and the customer profile as "Hardware Sales" | Caplight | | Value-chain position | Upstream crop-protection input developer, analogous to a biological active-ingredient registrant | Independent characterisation | | Customer types | Commercial row-crop growers (cotton, soybean, corn, sugar beet); likely routed through ag retailers or distributors and strategic partners | Series A release (2024) | | End-markets | US Southeast and Midwest row crops first; Brazil and Argentina named as Palmer markets | Global AgInvesting (2024) | | Go-to-market | Not publicly disclosed. The lead investor's network of US farmers is cited as an asset | Series A release (2024) |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2016
Center District, Israel
Verona

Verona Pharma PLC

Premium
Information Technology

Verona Pharma was a single-asset respiratory specialty pharmaceutical company that converted a four-decade-old molecule into one of the most successful commercial launches in modern respiratory medicine, and then monetised it. Its entire enterprise rested on ensifentrine — a first-in-class, inhaled, selective dual inhibitor of phosphodiesterase 3 and 4, marketed as Ohtuvayre — approved by the FDA on 26 June 2024 as the first novel inhaled mechanism for COPD maintenance treatment in more than twenty years. The Company self-commercialised in the United States through a roughly 120-representative field force and an exclusive specialty-pharmacy network, while out-licensing Greater China to Nuance Pharma. Quarterly net product sales rose from USD 5.6 million at launch to USD 102.9 million within four quarters, delivering the Company's first quarterly net income in Q2 2025. Fourteen months after approval, Merck acquired the business for approximately USD 10 billion — a valuation implying peak sales expectations of roughly USD 3–5 billion. --- ### The Company's own characterisation The Company described itself consistently across its final filings as *"a biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs"* (FY2024 Form 10-K, Item 1; Q2 2025 Form 10-Q, Item 2). Its 10-K described Ohtuvayre as *"our first commercial product and the first inhaled therapy with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years"* and stated the Company's belief that Ohtuvayre *"will redefine the treatment paradigm for COPD."* ### Independent characterisation Verona Pharma was, in structural terms, a single-molecule, single-market, asset-light commercial pharmaceutical company. Four features defined the model: **A single asset with multi-indication optionality.** Every dollar of enterprise value derived from ensifentrine. The Company acknowledged this explicitly as its foremost risk factor: *"We depend solely on the success of ensifentrine"* (FY2024 Form 10-K, Summary Risk Factors). The molecule's optionality lay in three vectors — additional indications (non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma), additional formulations (dry powder inhaler, pressurised metered-dose inhaler), and fixed-dose combinations (ensifentrine plus glycopyrrolate). **Asset-light manufacturing.** The Company owned no manufacturing facilities. It relied on a single contract manufacturing organisation (CMO) for ensifentrine drug substance and one CMO for each formulation of drug product (FY2024 Form 10-K, "Manufacturing"). This maximised return on invested capital but concentrated supply-chain risk to a degree unusual even for specialty pharma. **Direct US commercialisation, partnered ex-US.** In the United States the Company sold directly. Outside the United States, the stated strategy was to *"license Ohtuvayre to companies with expertise and experience in developing and commercializing products in those regions."* Only one such licence was ever executed — Nuance Pharma for Greater China (June 2021). **Medical-benefit reimbursement, specialty-pharmacy distribution.** Ohtuvayre is a nebulised inhalation suspension administered through durable medical equipment, and was reimbursed under the medical benefit rather than the pharmacy benefit — reflected in its permanent product-specific HCPCS J-code (J7601), effective 1 January 2025. Product moved through an exclusive network of five accredited specialty pharmacies (Q2 2025 Form 10-Q, "Concentration of risk"). ### Revenue model and mix | Revenue stream | Description | Materiality | |---|---|---| | US product sales (Ohtuvayre) | Net of distribution fees, government rebates and chargebacks, commercial chargebacks, returns, co-pay assistance and other fees | 100% of FY2024 revenue; 97.1% of H1 2025 revenue | | Licensing / milestone income | Nuance Pharma collaboration: USD 40.0m upfront (2021), up to USD 179.0m in clinical, regulatory and commercial milestones, tiered double-digit royalties on Greater China net sales | 100% of FY2021 revenue; 2.9% of H1 2025 revenue | | Clinical supply sales | Sale of clinical supply materials to Nuance Pharma | USD 0.458m in FY2022 only | | Subscription / service revenue | None | Nil in all periods | ### Value-chain position, customers and end-markets Verona occupied the discovery-adjacent-to-commercial band of the value chain: it did not discover ensifentrine (the compound, originally RPL554, was assigned to it via the 2005 Rhinopharma/Vernalis agreement, and traces to the GSK respiratory research programme led by Sir David Jack), and it did not manufacture. It owned clinical development, regulatory strategy, intellectual property, brand, pricing and US commercial execution. Its economic customers were the five specialty pharmacies that purchased product; its clinical customers were approximately 14,500 targeted US healthcare professionals — pulmonologists, internal-medicine physicians, primary-care physicians, nurse practitioners and physician assistants (FY2024 Form 10-K, "Commercialization"). Its ultimate payers were Medicare Part B, Medicare Advantage and commercial medical-benefit plans. End-markets served: COPD maintenance treatment (United States, commercial); COPD (Greater China, partnered, approved in Macau); and, in development, non-cystic fibrosis bronchiectasis, cystic fibrosis and asthma.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2005
Wales, United Kingdom
UPC

UPC Technology Corporation

Premium
Information Technology

UPC Technology Corporation is the world's largest producer and distributor of phthalic anhydride (PA) and PVC plasticizers. Its global market share is about 14–15% in plasticizers and 12–15% in PA, according to the November 2025 and March 2026 investor conferences. The company was founded in 1976 as Union Petrochemical Corp. and is part of the Lien Hwa–MiTAC conglomerate. It runs a vertically linked chain: PA and anhydride intermediates feed general-purpose and specialty plasticizers (DOP/DEHP, DINP, DINCH-type UniHydro® UN899), alongside ethylene-based PVC resin, unsaturated polyester resins, polyols and fatty esters. Logistics assets, including chemical jetties, tank farms and trucking, support the chain. UPC has seven to eight production and sales bases in Taiwan, mainland China and Malaysia. In FY2024, 87% of revenue came from China. That concentration ties the business closely to Chinese construction, autos and consumer-goods demand. After four loss-making years (FY2022–FY2025), the company returned to profit in 1H FY2026, helped by spread recovery, tariff-driven US demand for DINP, and a shift toward higher-value non-phthalate products. --- ### What the company does UPC Technology Corporation and its subsidiaries manufacture and sell petrochemical intermediates and polymer additives. Third-party profiles based on the company's own filings list these products: - phthalic anhydride - general-purpose plasticizers - specialty plasticizers: non-phthalate, polymeric, linear, adipate, trimellitate, bio-based and others - polyvinyl chloride - anhydrides and acids - unsaturated polyester resins - polyester polyol - fatty esters - other specialty chemicals for industrial use The group also provides logistics, terminal operations and pipeline transfer of bulk chemicals, road transportation and agency, chemical storage tanks, warehousing and consultancy, as well as investment, trading and real-estate management (Yahoo Finance / Snowball Analytics profiles, 2026). The company describes its business in three groups (Fugle summaries of the 27 Mar, 28 May and 27 Aug 2026 investor conferences): 1. **Core business:** general-purpose plasticizers (DEHP/DOP, DINP), anhydrides (PA) and PVC resin. This group generates almost all revenue. 2. **Specialty chemicals:** eco-friendly plasticizers (hydrogenated DINCH-type, polymeric/polyester plasticizers), unsaturated polyester resin (UPR) and polyester polyols. It also includes recycled-PET-derived sustainable plasticizers such as r-DOTP. 3. **Logistics and services:** chemical jetty handling, storage, transportation, customs agency and trading support. ### Company's own description A 2023 corporate profile filed with National Taipei University of Technology states the following. UPC began producing petrochemicals in 1976 and has built manufacturing and sales bases in Linyuan (Kaohsiung, Taiwan); Zhongshan, Zhuhai, Zhenjiang, Taizhou, Nanchong and Panjin in mainland China; and Kuantan in Malaysia. It claims more than 30% market share in Greater China and calls itself the world's largest PA and plasticizer manufacturer and channel company. The same profile says the company uses its core chemical platform to support specialty chemicals, warehousing, trading and logistics. It frames its competitive model around five words: scale, scope, differentiation, synergy and alliance. Management has repeated this framing in later investor presentations. ### Revenue model | Revenue line (product mix) | FY2025 share of revenue | 1Q FY2026 share of revenue | Source | |---|---|---|---| | Plasticizers | 81% | 80% | Fugle, 27 Mar 2026 and 28 May 2026 conference memos | | PVC | 11% | 12% | Same | | Anhydrides (PA and others) | 7% | 7% | Same | | Other / specialty / services (residual) | ~1% | ~1% | Derived residual | UPC is almost entirely a product-sales business. Volumes are priced off commodity benchmarks: ortho-xylene for PA, oxo-alcohols such as 2-EH and INA for plasticizers, and ethylene/VCM for PVC. Earnings are driven by the spread between product prices and feedstock costs, not by list pricing. Service revenue from logistics exists, but it is not separately quantified in accessible sources. There is no meaningful subscription or licensing income. ### Value-chain position UPC sits in the mid-stream of the petrochemical chain: **Inputs it buys:** ortho-xylene (for PA), and 2-ethylhexanol (2-EH) and isononyl alcohol (INA) for plasticizers. Key suppliers include ExxonMobil (a 10-year INA purchase contract, per CTEE) and BASF (an oxo-alcohol and catalyst MoU signed in August 2024). For PVC it uses ethylene-route VCM. **Integration:** PA is both sold externally and used internally to make plasticizers. Management adjusts the internal/external split to capture the better spread. In 1H FY2026 it kept PA mostly for internal use. From July 2026, after Chinese supply outages widened PA spreads, it planned to raise external PA sales (Fugle, 27 Aug 2026). **Outputs:** sold to PVC compounders and converters. About 90% of DOP is used in PVC, and about 60% of PVC goes into property-related uses (CNA, 21 Nov 2024). ### Customer types and end-markets | End-market | Products | Evidence | |---|---|---| | Construction / building materials (pipes, flooring, profiles, wall coverings) | PVC, DOP, DINP | ~60% of PVC demand is property-related (CNA, Nov 2024) | | Automotive (wire harness, underbody coatings, synthetic leather) | DINP, specialty plasticizers | Automotive DINP volume grew from 14 kt (2019) to 75 kt (2025), and was close to 80 kt in Jan–Aug 2026 (Fugle, Aug 2026) | | Wire and cable | DINP, TOTM | CTEE | | Medical devices, toys, food packaging, gloves | UniHydro® UN899 (non-phthalate) | Knowde product sheet | | Unsaturated polyester / composites | PA, MA, UPR | Company product list | | Polyurethane | Polyester polyol, PUD | Company product list | ### Independent characterization UPC is a scale-advantaged, spread-driven commodity intermediate producer. It is very concentrated in one geography (China) and one product family (plasticizers, about 80% of revenue). Its margins are thin even in good years: the peak gross margin over FY2021–FY2025 was 6.3%, in FY2021. It trades at a large discount to book value (P/B about 0.5x), which reflects four consecutive loss years. The company's strategic levers are: 1. mix migration from DOP to DINP and DINCH-type non-phthalates; 2. moving production geographically to Taiwan and Malaysia to capture tariff arbitrage; 3. owning logistics infrastructure on the Yangtze River; 4. long-term feedstock contracts.

RevenueN/A
EmployeesN/A
Market Cap$0.5B
Founded1976
Taipei City, Taiwan
Ueno

Ueno Fine Chemicals Industry Ltd.

Premium
Information Technology

| Field | Detail | Source / Fiscal reference | |---|---|---| | Legal name (Japanese) | 上野製薬株式会社 | Company website, corporate outline (2026) | | Legal name (English) | UENO FINE CHEMICALS INDUSTRY, LTD. | Company website | | Former names | Ueno Shoten (上野商店, sole proprietorship, 1918–1945); Ueno Seiyaku Kogyo K.K. (上野製薬工業株式会社, 1945–1955); renamed 上野製薬株式会社 in 1955 | Company history page | | Founding | August 1918, by Masajiro Ueno (上野政次郎) | Company outline | | Incorporation jurisdiction | Japan (Companies Act); registered head office in Chiyoda-ku, Tokyo since 2019 (previously Osaka) | Company history page (2019 entry) | | Corporate Number | 1120001077363 | National Tax Agency registry via Compalyze | | Headquarters (dual-HQ system) | Tokyo HQ: 2-5-6 Hirakawacho, Chiyoda-ku, Tokyo 102-0093. Osaka HQ: 2-4-8 Koraibashi, Chuo-ku, Osaka 541-8543 | Company office page | | Stock exchange / ticker | None – unlisted | — | | ISIN / CUSIP | Not applicable (no listed securities) | — | | Share capital | ¥1,010 million | Company outline; FY2026 statutory notice | | Fiscal year end | 31 May | Compalyze (statutory filings) | | Employees (latest) | 298 (May 2026) | Company outline | | Employees trend (social-insurance insured headcount proxy) | 304 (Oct 2025) → 299 (Jul 2026) → 296 (Oct 2026); –2.6% YoY | Compalyze (Japan Pension Service data) | | Annual sales (latest) | ¥17,143 million (FY2026, year to May 2026) | Company outline | | Net income (latest) | approx. ¥0.96 billion (FY2026) | Statutory notice via Compalyze | | Total assets (latest) | approx. ¥22.0 billion (FY2026) | Statutory notice via Compalyze | | Accounting auditor (会計監査人) | Required by law (large company); firm name not publicly disclosed | Companies Act requirement; not disclosed | | Statutory auditor (監査役) | Jun Demizu (出水 順) | Company officer list (2026) | | Market capitalization | Not applicable – not publicly disclosed (unlisted) | — | | Website | https://www.ueno-fc.co.jp | — | | Representative directors | Masaya Ueno – Representative Director, Chairman & CEO; Hiroya Ueno – Representative Director, President & COO (since 6 Aug 2026) | Company officer list / news | | Overseas entities | Ueno Fine Chemicals Industry (USA), Inc. (New York); Ueno Fine Chemicals Industry (Thailand), Ltd. (Bangkok office; Bangpoo Industrial Estate plant) | Company outline / office page | | Group sister company | Ueno Food Techno Industry, Ltd. (株式会社ウエノフードテクノ), spun off from the food division in 2016 | Company history page | Ueno Fine Chemicals Industry is a 108-year-old, family-controlled Japanese specialty chemicals manufacturer whose franchise rests on a single proprietary process: the "UENO Process," a continuous industrial implementation of the Kolbe–Schmitt carboxylation reaction, developed after second-generation leader Ryuzo Ueno elucidated the reaction mechanism in 1961. The process yields high-purity aromatic hydroxycarboxylic acids – principally POB® (para-hydroxybenzoic acid) and BON6® (6-hydroxy-2-naphthoic acid) – which the company claims are supplied at world-leading share as monomers for liquid crystal polymers. Downstream, it converts these monomers into parabens (cosmetic, pharmaceutical and food preservatives), pigment intermediates (BON3®) and its own vertically integrated thermoplastic UENO LCP® engineering resin for fine-pitch connectors and electronics. It is therefore simultaneously a critical upstream supplier to, and a niche downstream competitor of, global LCP majors. With roughly ¥17bn in sales and about 300 employees, it is small in scale but strategically embedded in the electronics materials chain. --- ### What the company does Ueno Fine Chemicals Industry operates two business divisions that are explicitly designed to be organically linked: 1. **Chemical Products Division (化学薬品事業)** – Research, development, manufacture and sale of aromatic hydroxycarboxylic acids and their derivatives, produced primarily at the Yokkaichi Plant (Mie Prefecture). Key products are POB® and BON6® (LCP monomers), parabens (methyl-, ethyl-, propyl-, butyl-paraben and derivatives), BON3® (3-hydroxy-2-naphthoic acid, a dye and pigment intermediate), resin additives, and developmental ligands for porous coordination polymers / metal-organic frameworks (PCP/MOF). 2. **LCP Division (LCP事業)** – Polymerization of the company's own POB® and BON6® monomers into thermotropic liquid crystal polyester base resins, and compounding with glass fibre, minerals and other fillers into finished grades marketed as UENO LCP®, produced primarily at the Itami Plant (Hyogo Prefecture), with additional neat-resin capacity at Yokkaichi since 2021. ### Company's own description (paraphrased from the latest website corporate pages, 2026) The company describes itself as a comprehensive chemical manufacturer composed of two divisions – chemical products and LCP resins – that places particular emphasis on in-house R&D, operating under the policy of researching and developing novel substances with functional properties. It states that the chemical products business uses the continuous Kolbe–Schmitt "UENO Process" as its core technology to produce fine chemicals not made by other companies and supply them worldwide, while the LCP business leverages the company's position as a global LCP monomer producer to offer a proprietary, flame-retardant thermoplastic polymer covering high-flow, heat-resistant, high-strength and general-purpose grades. The corporate philosophy is "Creativity and Originality" (創意工夫). The chairman's message emphasizes a shift from a product-out to a market-in orientation, a strengthened sales and marketing function, global information gathering, and the provision of technical information alongside physical product. ### Business model and revenue model | Dimension | Characterization | |---|---| | Revenue model mix | Essentially 100% product sales (tonnage-based specialty chemicals and engineered resin). No subscription or licensing revenue is disclosed; technical service is bundled with product. Custom processing is listed by third-party profiles as a service but no revenue is disclosed. | | Pricing model | Contract and spot pricing per kilogram/tonne, with periodic price revisions passed through to customers (UENO LCP® price revision notices published June 2021 and June 2024). | | Value-chain position | Upstream-to-midstream: buys commodity aromatic feedstocks (phenol, 2-naphthol, CO2, alkali) → produces high-purity monomers (POB®, BON6®) → sells monomers to third-party LCP polymerizers and consumes part internally → polymerizes and compounds UENO LCP® → sells pellets to injection molders and electronics component makers. In the paraben chain it sells to cosmetic, pharmaceutical and food formulators, generally via distributors. | | Customer types | (a) Global LCP resin producers (evidence: US customs records show shipments from Ueno to Ticona – Celanese's LCP manufacturing unit – at Grover, North Carolina, in February 2025 under organic chemicals HS chapter 29); (b) connector and electronic component makers and injection molders; (c) cosmetics, pharmaceutical and food manufacturers (parabens); (d) dye and pigment makers (BON3®); (e) thermal-paper and specialty-chemical producers (historically). | | End-markets | Smartphones, PCs, air-conditioners and other consumer electronics; automotive electronics; films and encapsulants; cosmetics and personal care; pharmaceuticals; food preservation; dyes and pigments; nylon plasticizers; emerging MOF/PCP and bio-based monomer markets. | ### Independent characterization Analytically, Ueno is best understood as a process-technology monopoly-type niche player embedded inside an oligopolistic electronics-materials chain. Its moat is not scale – at roughly ¥17bn of sales it is a fraction of the size of the LCP majors it supplies – but the decades-old know-how to run Kolbe–Schmitt carboxylation continuously, purify the products to polymer grade, and do so with remote-controlled, automated plants. This creates two economic profiles under one roof: **The monomer business:** behaves like a specialty intermediate franchise: high switching costs (polymer-grade purity is qualified into customers' LCP recipes), few credible global suppliers of BON6® in particular, and demand tied to global LCP volumes, which in turn track smartphone, PC and automotive connector cycles. **The UENO LCP® business:** behaves like a sub-scale engineering-plastics compounder that competes against its own customers. Its advantage is captive monomer supply and molecular-design flexibility (it offers base resins from the low-melting 8000/8100 series to the high-heat 6000 series); its disadvantage is limited scale versus Polyplastics, Celanese, Sumitomo Chemical, Toray and fast-growing Chinese producers. The FY2025 net loss (≈–¥0.88bn) followed by a FY2026 recovery (≈+¥0.96bn net income on 17% revenue growth) suggests high operating leverage and cyclical sensitivity to electronics demand and input costs – consistent with a capital-intensive continuous-process manufacturer with a thin equity cushion (equity ratio ≈14–18%).

Revenue$0.1B
Employees298
Market CapN/A
Founded1918
United States, North America
Tianjin

Tianjin Rianlon Chemical Co., Ltd.

Premium
Information Technology

| Item | Detail | Source | |---|---|---| | Current legal name | 天津利安隆新材料股份有限公司 (Tianjin Rianlon New Materials Co., Ltd.) | H1 2026 Interim Report | | English name | Rianlon Corporation (RC) | H1 2026 Interim Report | | Former name | 利安隆(天津)化工有限公司 — Rianlon (Tianjin) Chemical Co., Ltd. (2003–2013) | H1 2026 Interim Report, Note III | | Founding / incorporation date | 8 August 2003 (S&P profile states 2007 — conflicts with the company's own filing; company filing preferred) | H1 2026 Interim Report; StockAnalysis profile | | Incorporation jurisdiction | People's Republic of China (Tianjin, TEDA) | FY2024 Annual Report | | Unified Social Credit Code | 911201167522185471 | H1 2026 Interim Report | | Registered address | No. 6 Huangshan Road, Hangu Modern Industrial Zone, TEDA, Tianjin 300480 | FY2024 Annual Report | | Head office | 20F, Block F, No. 20 Kaihua Road, Huayuan Industrial Zone, Nankai District, Tianjin 300384 | FY2024 Annual Report | | Exchange / ticker | Shenzhen Stock Exchange, ChiNext — 300596 (short name 利安隆) | FY2024 Annual Report | | ISIN | CNE100002MQ2 | StockAnalysis / SZSE profile | | CUSIP | Not applicable (no US listing) | — | | Share capital | 229,619,667 A-shares, 100% unrestricted as of 30 June 2026 | H1 2026 Interim Report | | Fiscal year end | 31 December | FY2024 Annual Report | | Legal representative | Fan Xiaopeng (范小鹏) — per H1 2026 report (FY2024 report listed Li Haiping) | H1 2026 Interim Report | | Chairman & President; actual controller | Li Haiping (李海平); ~25.05% combined indirect stake | H1 2026 Interim Report; Eastmoney/Tianyancha summary (Aug 2026) | | Auditor | Baker Tilly China (天职国际会计师事务所(特殊普通合伙)); standard unqualified opinions FY2024 (Tianzhi Ye Zi [2025] 14766) and FY2025 (Tianzhi Ye Zi [2026] 20716); auditor changed to Baker Tilly in FY2024 (predecessor auditor not named in sources reviewed) | FY2024 AR; FY2025 Audit Report | | Employees (latest) | 3,068 (latest annual report, FY2025) | Eastmoney summary citing latest AR, Aug 2026 | | Market capitalization | CNY 9,031 M (29 Sep 2026; close CNY 39.33 on 30 Sep 2026); EV CNY 11,150 M | S&P std. via StockAnalysis | | Website | www.rianlon.com; IR e-mail sec@rianlon.com; tel. +86 22 8371 8775 | FY2024 AR | | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Total employees (headcount) | 3238 | 3153 | 3068 | | R&D personnel | 442 | 445 | n/d | Note: FY2023 total headcount is derived (442 R&D staff ÷ 13.65% R&D share, FY2024 AR); FY2024 is reported (parent 464 + main subsidiaries 2,689, FY2024 AR); FY2025 is per the latest annual report as cited by Eastmoney (Aug 2026). The FY2024 workforce split was: production 1,552; technical 870; administrative 537; sales 132; finance 62; by education 10 PhDs, 144 master's, 907 bachelor's, 2,092 diploma or below. Outsourced labour amounted to 2.70 million hours costing CNY 96.4 M in FY2024. Rianlon is China's largest producer of polymer anti-aging additives — antioxidants (RIANOX), light stabilizers including UV absorbers and HALS (RIASORB), and customized one-pack blends (U-pack®) — and describes itself as one of only two companies globally offering a full-range anti-aging portfolio, the other implicitly being BASF. Built by a founding team from Tianjin University's chemical engineering faculty, it operates a "dual-base" supply model in which every core product is made at two or more Chinese sites. Since 2022 it has added a second growth engine in lubricant additives through Jinzhou Kangtai, positioned as a domestic substitute for the Western "big four", and incubated life-science building blocks and electronic-grade polyimide via the 2024 acquisition of Korea's IPITECH. FY2025 revenue was CNY 6.02 bn with CNY 497 M net profit. Its strategic pivot is now toward globalized capacity (Johor, Malaysia) and a partnership with Infineum. --- ### What the company does Rianlon manufactures specialty chemical additives that are dosed in small quantities into large-volume host materials — plastics, coatings, rubber, fibers, adhesives and lubricating oils — to protect them against thermal-oxidative, photo-oxidative and mechanical degradation. The economic logic is "small dosage, large effect": additives are a minor fraction of a customer's bill of materials but determine whether a polymer part or lubricant meets its service-life specification, which creates qualification barriers, long approval cycles and sticky customer relationships (SZSE company profile; FY2024 AR). ### Company's own description (paraphrased from H1 2026 Interim Report and FY2024 AR) The company characterizes itself as a global "chemistry and biotechnology platform" enterprise whose mission is to create a colourful life through chemistry and biology and whose ambition is a century-old Rianlon brand. Management organizes the business into three "life curves": (1) polymer anti-aging additives — described as "the rice in the pot", the cash-generative core whose goal is global top-tier status; (2) lubricant additives — "the grain in the barn", a scale business positioned as a backbone of domestic substitution; and (3) life sciences — "the rice in the field", an R&D-heavy option on the future. A fourth, separately-managed emerging line covers electronic-grade polyimide (PI) and, since late 2025, electronic adhesives. The organization runs on a "headquarters + business division" model in which each division owns R&D, production, supply chain and sales (H1 2026 Interim Report, MD&A). ### Independent characterization Rianlon is best understood as a mid-cap, vertically integrated Chinese specialty-additives producer whose earnings remain ~80% dependent on a cyclical, increasingly commoditized polymer-additive franchise, onto which management has bolted a lower-margin but faster-growing lubricant-additive business and several venture-like options. Its competitive moat rests on (a) breadth of portfolio, (b) multi-site redundancy, (c) cost position in China, and (d) long qualification histories with global polymer majors. Its weaknesses are a balance sheet that has steadily re-levered (total debt CNY 3.76 bn at FY2025 vs. CNY 1.48 bn at FY2021), structurally weak free-cash conversion, and margins well below pre-2023 levels after a domestic price war. The 2026 strategic narrative — Johor capacity, the Infineum alliance and EU/Japanese capacity retreat — is the most important swing factor for re-rating. ### Business and revenue model | Dimension | Characterization | |---|---| | Revenue model | ~100% product sales (B2B industrial chemicals); no subscription/licensing revenue disclosed. "Other business revenue" was CNY 18.3 M in FY2024 (0.32% of revenue) | | Sales channel | Direct sales 91.68% (CNY 5,214.0 M) and distributors 8.32% (CNY 472.9 M) in FY2024; distribution grew 26.96% YoY (FY2024 AR) | | Revenue recognition | Point-in-time on delivery (domestic) or customs declaration/bill of lading (export) (H1 2026 report, accounting policies) | | Value-chain position | Mid-stream: buys petrochemical intermediates (alkylphenols, fatty alcohols/ketones, fatty acids/esters, aromatic amines, inorganics) and sells formulated or single-component additives to polymer producers, compounders, coatings makers, lubricant blenders and additive majors | | Customer concentration | Low: top-5 customers = 13.51% of FY2024 sales (largest 4.38%); top-5 suppliers = 24.46% of purchases (FY2024 AR) | | Customer types | Global and Chinese polymer producers and compounders, coatings/adhesive makers, fiber producers, national oil companies (Sinopec, PetroChina), international oil companies and international additive companies (lubricants), biotech/CDMO and IVD reagent makers (life sciences), flexible-display and FPC makers (PI) | | End-markets | Automotive & transportation (incl. NEV), building & construction, agriculture films, electronics & electrical, packaging, textiles, sports & leisure, household goods, renewable energy (PV/EVA film, energy storage), personal care, healthcare, fuels & lubricants (S&P business description; FY2024 AR) | ### Key raw-material exposures (FY2024 AR) | Raw material category | Share of total purchases FY2024 (%) | H1 2024 avg price (CNY/kg) | H2 2024 avg price (CNY/kg) | |---|---|---|---| | Alkylphenols | 19.25 | 12.01 | 11.95 | | Fatty ketones/alcohols | 15.71 | 8.40 | 7.42 | | Fatty acids & esters | 8.86 | 13.32 | 13.73 | | Inorganic compounds | 8.66 | 3.24 | 3.17 | | Aliphatic hydrocarbons | 5.25 | 12.86 | 10.72 | | Aromatic amines | 3.82 | 13.68 | 12.56 | | Aliphatic thiols | 2.66 | 24.65 | 24.41 | | Coal (CNY/t) | 1.23 | 537.68 | 480.93 |

Revenue$0.8B
Employees3,068
Market CapN/A
Founded2003
United States, North America
The

The Andhra Pradesh Mineral Development Corp

Premium
Information Technology

APMDC is the Government of Andhra Pradesh's nodal mining company. For five decades it was a single-asset barytes producer built on the Mangampet deposit, widely described as the world's largest single barytes deposit, and it supplies roughly 90 to 95% of India's barytes output. Since March 2022 it has become a two-commodity business through the Suliyari thermal coal mine in Madhya Pradesh, which lifted revenue from INR 1,155 crore in FY2022 to INR 3,841 crore in FY2024. In 2025 it changed character again. It raised about INR 9,000 crore of 9.30% state-guaranteed bonds to buy quarry rights over 436 minor mineral projects from its own shareholder, moving gearing from 0.16x to 2.32x. The company today is therefore best understood as a profitable but depleting barytes franchise, a contracted coal annuity, and a large, state-backed and as yet unproven minor-minerals and beach-sand option, whose credit quality rests more on GoAP than on its own balance sheet. --- **The company's own description.** The KID of May 2025 describes APMDC as the nodal company of the State, holding rights to mine and explore minerals both within and outside Andhra Pradesh. It states that although equipped for integrated mining, the company currently delegates mining operations to a selected Mine Developer and Operator (MDO) on contract after providing the land free of encumbrances. It lists barytes as the active major mineral, with granite and ball clay as minor minerals, and says it has "forayed into" thermal coal, coking coal, beach sand minerals and iron ore. **Independent characterisation.** APMDC is an asset-owning, contractor-operated resource company. It holds leases and statutory rights, tenders excavation and haulage to contractors and MDOs, and sells output through tenders, e-auctions and long-term supply agreements. Its economics are those of a royalty-like rights holder with operating exposure. - Fixed assets are light: property, plant and equipment was INR 78.99 crore at March 2024. - Intangible mining rights are heavy: INR 2,043.12 crore at March 2024. - EBITDA margins sit around 38 to 42%. **Revenue model.** Revenue is almost entirely product sales of minerals. There is no subscription, licensing or service revenue of substance. Other income, largely interest on deposits, was INR 128.90 crore in FY2024 (KID). **Barytes:** Sold directly by APMDC through an annual e-tender cum e-auction in which quantity and price are fixed for one year. The highest bidder receives the largest allocation. CARE (Mar 2026) names Varshini Exim Private Ltd, Gimpex Private Ltd and Emprada Mines & Minerals Pvt Ltd as holders of fixed-price sale agreements. The balance goes to pulverising mills and chemical units. **Coal:** About 75% of Suliyari output is sold to Adani Power Limited under long-term fuel supply agreements (CARE). The remainder is sold to Madhya Pradesh MSMEs through spot e-auctions on the M-Junction platform. One example is 125,000 tonnes of G-7 grade coal at a base price of INR 2,533 per tonne, auctioned on 5 June 2026 (APMDC notice on Coaljunction). **Survey stones and minor minerals:** Granite survey stones, black galaxy granite, ball clay and calcite. **Value chain position.** Upstream only: exploration, lease holding, mining and ex-mine sale. Beneficiation and downstream processing (barytes pulverising, beach-sand mineral separation, titanium value addition) are aspirations pursued through joint venture and MDO tenders, not operating businesses today. **Customers and end-markets.** - Barytes: merchant exporters and processors serving oil and gas drilling fluids, plus chemical, paint, rubber and plastics fillers. - Coal: thermal power generators and MSMEs. - Minor minerals: construction, dimension stone and ceramics. - Historically cited domestic barytes consumers include ONGC and Indian Oil (Business Standard, June 2012).

Revenue$0.3B
EmployeesN/A
Market CapN/A
Founded1961
Vijayawada, India
TERNIUM

TERNIUM ARGENTINA SOCIEDAD ANON

Premium
Information Technology

Ternium Argentina is the country's dominant integrated flat-steel producer and the Argentine listed arm of the Techint group's Ternium S.A. It runs a blast-furnace route integrated mill in Ramallo/San Nicolás (Buenos Aires province) feeding cold-rolling and coating operations in Ensenada and processing and service centres around the province, selling hot-rolled, cold-rolled, galvanized, pre-painted, Cincalum and tinplate products to construction, automotive, appliance, agricultural-machinery, packaging and energy customers. In 2021 it held about 93% of the domestic flat-steel market. Its earnings are unusual for an industrial company: beyond steel operations, it holds a 28.7% stake in Ternium México (carried at about USD 2.4 billion at end-2025) and a small Usiminas interest, plus a large Argentine-bond-heavy treasury portfolio. As a result, reported profit is often driven more by associate earnings, deferred taxes and financial results than by Argentine steel margins, which compressed sharply in 2024–2025 amid recession and import pressure. --- **What the company does.** Ternium Argentina's corporate purpose, per Article 2 of its bylaws, is the promotion, construction and operation of steel plants; the production and sale of pig iron, steel, iron and steel products; financial operations and investments in other companies' shares; and, since the 2025 merger with Vientos Olavarría, the generation and sale of electric power (FY2025 FS, Note 1). In practice it is a vertically integrated flat-steel maker: it reduces iron ore in blast furnaces, makes steel, hot-rolls slabs into coils, and then cold-rolls, coats and processes them into finished flat products. **Company's own description.** The FY2021 annual report (as quoted by iProfesional) stresses that "the industrial integration of Ternium Argentina allows the company to offer tailored products and services, under a solid differentiation strategy versus its competitors." The FY2025 report describes plans to keep advancing an investment plan "focused on operational efficiency, safety and the environment," and warns that rising imports "under unfair trade conditions" threaten activity in the steel value chain, including its customers. **Business model and revenue mix.** Revenue is almost entirely product sales recognized at a point in time when control passes to the customer, mainly through direct sales (FY2025 FS, Note 3(q)). There is no subscription or licensing revenue. Minor service-like income includes commercial commissions (ARS 2,678 million in FY2025, Note 9). Electricity generation from the merged wind farm is primarily for self-consumption rather than a revenue line. **Value-chain position.** Upstream it buys iron ore, metallurgical coal/coke, ferroalloys, natural gas, power and industrial gases (oxygen, nitrogen, argon under a USD 52.0 million contract running to 2037). Midstream it produces and rolls steel. Downstream it sells to OEMs, processors, distributors and its own service centres, and since January 2026 into welded tubes through Tubos Argentinos. It pays brand-use royalties to the Ternium group (ARS 24,720 million in FY2025 selling expenses, Note 6). **Customer types and end-markets.** Construction, automotive, home appliances (línea blanca), agricultural machinery, packaging (tinplate), transport and energy. In 2025 demand was led by energy (gas and oil infrastructure, notably Vaca Muerta pipelines), agribusiness and mining, while metal-mechanical and appliance demand stayed weak because of soft consumption and import competition (FY2025 annual report as reported by iProfesional; 1Q2026 press release). **Independent characterization.** Ternium Argentina is best understood as three businesses inside one listed shell: (1) a cyclical, domestically focused integrated flat-steel franchise with near-monopoly share but thin current margins; (2) a holding company whose largest asset by book value is a minority stake in Ternium México (ARS 3.43 trillion carrying value versus ARS 1.28 trillion of PP&E at end-2025); and (3) a treasury that held roughly USD 0.75–0.80 billion of cash and investments, mostly Argentine sovereign USD bonds, through 2025–1H2026. The listed equity therefore trades on Argentine macro risk, steel-import policy, Mexican steel results and controlling-shareholder decisions about dividends in kind.

RevenueN/A
Employees5,353
Market CapN/A
Founded1962
United States, North America
Teh

Teh Fong Min International Co., Ltd.

Premium
Information Technology

### Key facts | Item | Detail | Source / note | |---|---|---| | Legal name | Teh Fong Min International Co., Ltd. (德豐銘國際股份有限公司) | Company website; EMIS profile | | Alternative spellings | Teh Fong Ming International Co., Ltd.; brand abbreviation "TFM" | Commerce FR notices 2012–2026 | | Former names | None identified | Not publicly disclosed | | Founding year | 1992 (company history: "TFM was founded (Tai-shan Plant)") | tfmintl.com.tw, Company History page | | Incorporation date | 8 June 1993 (registry-derived) | EMIS company profile. Discrepancy: the website gives 1992 as the founding year. The likely explanation is that operations or the plant began in 1992 and the company-limited-by-shares was registered in 1993. | | Incorporation jurisdiction | Republic of China (Taiwan) | EMIS; website | | Headquarters | No. 84, Minzu West Road, Datong District, Taipei City 10365, Taiwan | Website; EMIS; U.S. bills of lading | | Telephone / e-mail | +886-2-2535-1178; info@tfmintl.com.tw | Website | | Stock exchange / ticker | None (unlisted) | No TWSE/TPEx listing found | | ISIN / CUSIP | Not applicable (no listed security) | — | | Fiscal year end | Not publicly disclosed (Taiwanese companies conventionally use 31 December) | — | | Employees | Not publicly disclosed; no 3-year trend available | — | | Auditor | Not publicly disclosed | — | | Market capitalization | Not applicable (unlisted) | — | | Website | www.tfmintl.com.tw | Company | | Industry classification | Other basic inorganic chemical manufacturing (EMIS); chemicals and chemical preparations n.e.c., SIC 2899 (Kompass) | EMIS; Kompass | | Core product | Stilbene-based fluorescent whitening agents (FWAs) / optical brightening agents (OBAs), principally for papermaking, under the TAFLUONOL brand | USPTO Serial No. 77127599; USITC Pub. 4322 (2012) | | Key subsidiaries / affiliates | TFM North America, Inc. (Vancouver, Washington, USA; founded 2006); Teh Fong Min Europe B.V. (Netherlands; founded 2011) | Website; Commerce FR notices | Teh Fong Min International is a family-scale but globally significant Taiwanese specialty-chemicals manufacturer. It is focused on stilbene-based optical brightening agents, the fluorescent compounds that paper mills add to offset the natural yellow cast of pulp. TFM describes itself as one of the world's largest OBA producers. Its main brand is TAFLUONOL. It produces in Taiwan at its original Tai-shan plant and at the Lize (Yilan) plant opened in 2011, and it has operated a U.S. production line in South Carolina since 2015. U.S. trade-remedy records identify TFM as the dominant Taiwanese exporter of OBAs to the United States. Taiwan accounted for about 70–76% of U.S. stilbenic OBA imports in 2010–2011 (USITC Pub. 4322). Commercially, TFM competes against Archroma, the former Clariant paper business, and against large Chinese and Indian producers. It does so mainly on cost, continuous-process efficiency and purity claims. Its strategic overhang is a U.S. antidumping order that was revoked in 2022 and then reinstated in 2024. In parallel, it is diversifying modestly into engineered inorganic particles for cosmetics. --- ### What the company does TFM manufactures and sells fluorescent whitening agents, also called optical brightening agents or optical brighteners. These are synthetic organic compounds that absorb ultraviolet light and re-emit it as visible blue light. The effect masks yellowness in a substrate so that it looks whiter and brighter. TFM's core chemistry is the triazinylaminostilbene family. These molecules are built on 4,4′-diaminostilbene-2,2′-disulphonic acid (DAS), cyanuric chloride and aniline derivatives. The USITC describes the chemistry as follows (USITC Pub. 4322, May 2012): **Di-sulphonated grades:** are made with aniline and are usually added to pulp slurry ("wet end"). **Tetra-sulphonated grades:** are made with sulfanilic acid and are the most versatile. They can be used at the wet end, the size press or in coating. Fluorescent Brightener 220 is the most widely used product in this group. **Hexa-sulphonated grades:** are made with aniline disulphonic acid and are used mainly in surface coating. The Kompass directory characterises the Yilan operation as "production and sales of fluorescent brightening agents for papermaking." U.S. customs bills of lading consistently describe TFM's exports as "FLUORESCENT WHITENING AGENT". A representative example is a 6 March 2014 shipment of TAFLUONOL SCBP to TFM North America (Seair; Panjiva). ### The company's own description TFM's website describes the company as one of the largest OBA manufacturers in the world. It says the company has spent more than 30 years applying modern technologies and facilities to transform traditional chemical manufacturing (tfmintl.com.tw, Company History page, retrieved 2026). The current homepage lists the following product categories: **Pulp & Paper:** TFM describes a portfolio of paper chemicals used across all stages of papermaking. **Textile / Washing:** - Electronics Chemicals. **Advanced Functional Materials:** These are engineered inorganic particles with controlled spherical morphology, particle-size engineering and tailored surfaces. They target cosmetics, personal care, pharmaceutical formulations and life sciences. The homepage also lists commercial strengths: direct factory sales, acceptance of OEM/ODM orders, and acceptance of small orders. TFM does not publish an annual report. No "latest annual report" self-description therefore exists. The website is the closest equivalent. ### Independent characterisation TFM is best understood as a single-molecule-family, export-oriented intermediate-chemicals producer. It sits midstream in the paper-chemicals value chain. Its upstream inputs are DAS, which comes predominantly from China and to a lesser extent India, plus cyanuric chloride and aniline derivatives. Its downstream customers are pulp and paper mills producing uncoated and coated printing and writing paper, specialty paper, paperboard and tissue. **Business model.** The model is product sales of a commodity-like specialty chemical. Sales are mostly on contract, and price is a first- or second-order purchasing criterion. In the original U.S. investigation, 12 of 14 responding U.S. purchasers rated price "very important" (USITC Pub. 4322). **Revenue model.** Revenue is essentially 100% product sales. The company discloses no subscription, licensing or service revenue. Technical service to paper mills is bundled into product sales; TFM North America employed a technical services manager in 2011–2012. **Distinctive operating features documented in the public record:** 1. **Continuous production process.** At the 2012 USITC hearing, TFM testified that it makes OBAs in a continuous process. U.S. batch producers Clariant and 3V did not, while BASF ran a continuous process that started from toluene (USITC Pub. 4322, Part I). 2. **Powder logistics.** In 2011, the U.S. petitioner noted that foreign producers "such as TFM" had invested in spray-drying equipment. This lets them ship concentrated powder that is "let down" into aqueous solution near the customer (USITC preliminary conference transcript, 21 April 2011). The USITC later found that 87% of subject imports in its pricing data arrived in powder form, which gives a freight-cost advantage (USITC Pub. 4322, fn. 129). 3. **Purity positioning.** TFM argued that its OBAs had higher purity and lower impurity-driven yellowing than U.S. product. The USITC did not accept this as a basis for non-substitutability. 4. **Affiliated distribution.** In the United States, TFM sells through its wholly affiliated importer, TFM North America, Inc. In Europe it sells through Teh Fong Min Europe B.V. **End-markets.** - Paper and board is dominant by all available evidence. - Textiles, laundry/washing and electronics chemicals appear as secondary categories. - Cosmetics and personal care is a nascent adjacency via Advanced Functional Materials. **Customer types.** Integrated pulp and paper mills, independent paper mills, specialty paper converters, and (for non-paper lines) textile finishers and formulators. U.S. bill-of-lading data show 17–21 identified consignees and notify parties across TFM's U.S. trade history (Panjiva, 2026). The overwhelming majority of shipments go to TFM North America, which then sells to mills.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1992
Taipei City, Taiwan
Tayca

Tayca Corporation

Premium
Information Technology

| Item | Detail | |---|---| | Legal name | テイカ株式会社 / TAYCA CORPORATION | | Former names | 帝国人造肥料株式会社 (Teikoku Jinzo Hiryo, 1919–1942); 帝国化工株式会社 (Teikoku Kako, 1942–1989) | | Founded | December 1919 (incorporated to manufacture superphosphate fertiliser) | | Incorporation jurisdiction | Japan (Companies Act); governance form: company with an Audit and Supervisory Committee | | Registered head office | 1-3-47 Funamachi, Taisho-ku, Osaka 551-0022 (site of the Osaka Plant) | | Corporate / IR office | 4-11-6 Tanimachi, Chuo-ku, Osaka (per Shared Research company profile) | | Tokyo branch | Shin-Nihon Building 4F, 3-8-2 Nihonbashi, Chuo-ku, Tokyo | | Exchange and ticker | Tokyo Stock Exchange Prime Market, securities code 4027 (listed May 1949; Prime since 4 April 2022) | | ISIN / CUSIP | no CUSIP for a TSE-only listing) — confirm with JPX | | Fiscal year end | 31 March | | Employees (consolidated) | 862 (31 March 2026); parent company 577 | | Auditor | Seiryo Audit Corporation (清稜監査法人); continuous audit period 3 years; audit fee JPY 30M (FY3/2026) | | Shares issued | 22,914,414 (after cancellation of 1,000,000 treasury shares on 27 May 2026) | | Treasury shares | 252,831 (30 June 2026) | | Share price | JPY 2,311 (close, 7 October 2026) | | Market capitalisation | ≈JPY 52.4bn (22.66M shares outstanding ex-treasury at 30 June 2026 × JPY 2,311) | | Website | https://www.tayca.co.jp/ | | Consolidated subsidiaries | 8 at 31 March 2026 (7 after the absorption of TFT Co., Ltd. on 1 April 2026) | The entity profiled is TAYCA CORPORATION (テイカ株式会社), Osaka, Japan, a listed company on the Prime Market of the Tokyo Stock Exchange. The "Public company" classification in the input list is correct. | Metric | FY3/2026 | |---|---| | Consolidated employees | 862 | | of which Functional Materials | 331 | | of which Electronic Materials & Chemicals | 349 | | of which Other | 112 | | of which Corporate | 70 | | Parent employees | 577 | | Parent average age (years) | 40.5 | | Parent average tenure (years) | 17.0 | | Parent average salary (JPY thousand) | 6674 | Source: FY3/2026 Yuho. Tayca is a 107-year-old Osaka specialty-inorganic and fine-chemicals manufacturer that has evolved from a sulphuric-acid and fertiliser maker into a niche materials supplier built on three core technologies: inorganic/organic synthesis, particle surface treatment, and dispersion/stabilisation. Its legacy anchor is sulphate-process titanium dioxide pigment from the Okayama Plant, a commoditising business now under severe pressure from Chinese imports that forced a JPY 3.17bn impairment in FY3/2026. Around that core, Tayca built globally relevant niches: ultrafine titanium dioxide and zinc oxide used as mineral UV filters in sunscreens, oxidant/dopant chemistries for conductive-polymer capacitors used in vehicles and AI servers, linear alkylbenzene sulphonate surfactants produced in Japan, Thailand and Vietnam, and piezoelectric ceramics and single crystals for medical ultrasound via US subsidiary TRS Technologies. The May 2026 "MOVING-10 STAGE3" plan pivots capital toward electronics and medical piezo, restructures titanium dioxide, and commits at least JPY 20bn to shareholder returns. --- ### The company's own description In its FY3/2026 Annual Securities Report, Tayca describes the group as the parent plus eight consolidated subsidiaries whose principal business is the manufacture and sale of chemical industrial products and piezoelectric materials, plus the transport and storage of chemicals. Its corporate philosophy is to use the power of chemistry to create "sources of inspiration" and deliver dreams and smiles worldwide; the operating slogan in recruitment and IR materials is "まじめに感動素材" (earnestly creating inspiring materials). The company's statement of its value-creation logic, in the section on its basic policy on corporate control, traces a lineage from sulphuric-acid technology to titanium dioxide and surfactants, and from accumulated surface-treatment, dispersion and sulphonation know-how to high-value products such as cosmetic-grade ultrafine titanium oxide, surface-treated products and conductive-polymer agents for high-performance capacitors. ### Independent characterisation Tayca is best understood as a two-speed materials company. Roughly half of revenue (Functional Materials, JPY 26.2bn in FY3/2026) is titanium-dioxide-based: a commodity pigment line facing structural decline in Japan and price competition from Chinese sulphate- and chloride-route producers, and a higher-value cosmetic ultrafine-particle line exposed to inventory cycles at global sunscreen formulators. The other half (Electronic Materials & Chemicals, JPY 30.0bn in FY3/2026 on the old segment definition) combines a stable, low-growth ASEAN surfactant franchise with two genuinely growing technology niches: conductive-polymer capacitor chemicals and piezoelectric materials. The investment case therefore turns on whether the growth niches can scale fast enough, and whether management can stop the titanium-dioxide franchise from destroying value, while the balance sheet (68.9% equity ratio, JPY 17.6bn of investment securities) is recycled into returns. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | Almost entirely product sales of manufactured chemicals and materials; minor service revenue from warehousing, logistics and plant engineering (Other segment, JPY 1.15bn external sales in FY3/2026). No subscription or licensing revenue is disclosed. | | Production model | Make-to-stock; the company states it does not engage in build-to-order production (FY3/2026 Yuho). | | Value-chain position | Mid-stream intermediate/ingredient supplier. Buys ilmenite/titanium ore (imported), sulphur/sulphuric acid inputs, petrochemical alkylbenzene and specialty monomers; sells to paint, ink, plastics, cosmetics, detergent, capacitor and ultrasound-probe manufacturers. | | Customer types | Paint makers (e.g., Kansai Paint, Dainichiseika, Dai Nippon Toryo, Asahipen, Kikusui Chemical — all disclosed as customers in the cross-shareholding register), global cosmetic/sunscreen formulators and OEMs, household-detergent and hair-care producers, chemical companies (NOF, Toho Chemical, Daiichi Kogyo Seiyaku, Sugai Chemical, Niitaka), capacitor manufacturers, medical ultrasound OEMs, and trading houses (Mitsubishi Corp., Mitsui & Co., Sumitomo Corp., Sojitz). | | End-markets | Architectural and industrial coatings, printing inks, plastics, paper; sunscreens and colour cosmetics; household detergents and personal care; automotive electronics, AI servers, telecom base stations, PCs/smartphones; medical diagnostic ultrasound; industrial sensors. | | Purchased goods | JPY 1.63bn of merchandise purchased for resale in FY3/2026 (2.8% of sales), indicating a predominantly manufacturing model. | ### Production and sales by segment (FY3/2026, old segment basis) | Metric (JPY M) | Functional Materials | Electronic Materials & Chemicals | Other | Total | |---|---|---|---|---| | Production value (at selling prices) | 25759 | 29449 | 0 | 55208 | | YoY production change (%) | -15.3 | 17.6 | 0 | -0.5 | | Merchandise purchases | 312 | 1316 | 0 | 1629 | | Sales | 26213 | 30007 | 1152 | 57373 | | YoY sales change (%) | -8.0 | 14.9 | 3.0 | 2.9 | Source: FY3/2026 Yuho, Section "Production, Orders and Sales".

Revenue$0.4B
Employees862
Market CapN/A
Founded1919
United States, North America
Supreme

Supreme Petrochem Ltd.

Premium
Information Technology

Supreme Petrochem is India's dominant producer of styrenic polymers, with more than 50% domestic share in polystyrene (PS) and expandable polystyrene (EPS). It operates the country's only extruded polystyrene (XPS) insulation-board plant and, since September 2025, India's first continuous mass-ABS line (70,000 TPA, licensed from Versalis/Eni). The company is a joint venture of two Mumbai business families: the Taparias (The Supreme Industries, India's largest plastics processor) and the Rajan Raheja group. It converts imported styrene monomer into PS, EPS, ABS, compounds, masterbatches and XPS at a single integrated complex at Amdoshi (Raigad, Maharashtra) and an EPS plant in Chennai. It also trades styrene monomer, which supplied about 20% of FY26 turnover. Earnings follow the styrene–polymer spread cycle. The balance sheet has no borrowings, ₹874 cr of investable surplus (June 2026) and a 60% payout policy in practice. The strategy is to move the mix from commodity PS/EPS toward engineering plastics (ABS, compounds) and building insulation while defending scale leadership against imports. --- **What the company does.** SPL is a downstream petrochemical manufacturer in the styrenics value chain. It does not produce styrene monomer (SM) itself, which is in structural deficit in India. Instead it imports SM, mainly from the Middle East, Singapore and East Asia, and polymerises it into: - general-purpose and high-impact polystyrene (GPPS, HIPS); - expandable polystyrene beads (EPS, sold to moulders who make "thermocol"); - mass acrylonitrile-butadiene-styrene (ABS); - specialty polymer compounds (SPC) and masterbatches based on styrenics, PP and nylon; - XPS rigid insulation boards. It also resells imported SM to domestic users, a lower-margin trading activity. **The company's own description.** In its FY26 BRSR and investor decks, SPL describes itself as primarily a B2B supplier serving original equipment manufacturers (OEMs) and a broad range of manufacturers. Named end uses include: - air-conditioner, refrigerator and washing-machine OEMs; - air-cooler and geyser housings, household goods, cutlery, dairy packaging, TV and computer parts, stationery and imitation jewellery; - protective packaging for electricals; - fisheries, produce and pharmaceutical packaging; - blocks and sheets for false ceilings. The investor deck calls the Amdoshi site "India's first truly international scale state-of-art Styrenics complex" and claims market leadership in PS and EPS with a share above 50%. **Revenue model.** SPL earns essentially all of its revenue from product sales. It has no subscription, licensing or service income. Pricing is not publicly disclosed product by product. Commentary from management and CRISIL shows that polymer prices track international SM and polymer benchmarks, so profitability is driven by the "delta" (spread) between SM and finished polymer rather than by absolute price. The Q1 FY27 call cited GPPS deltas widening by about US$200/t and HIPS by US$300–400/t. Raw-material inventory of 30–40 days, plus 4–6 weeks of material in transit (CRISIL), creates inventory gains when prices rise and losses when they fall. **Value-chain position.** The chain runs: crude/naphtha → benzene + ethylene → styrene monomer (imported) → SPL polymerisation → converters and moulders (injection moulding, thermoforming, EPS moulding, compounding) → OEMs and end markets. Promoter Supreme Industries is itself a downstream converter, and related-party sales were 2.42% of SPL's sales in FY26 (BRSR). **Customer types and channels.** - Sales are mostly direct. - Dealers and distributors handled 11% of sales in FY26 (8% in FY25), through 14 distributors; the top 10 accounted for 98% of distributor sales (BRSR). - The customer base is split between OEMs and non-OEM processors (CRISIL). The non-OEM segment is the more price-elastic: it cut purchases sharply when SM prices spiked in Q1 FY27. - Customers are in about 100 countries. - SPL holds Three Star Export House status, valid to 31 March 2028. **End markets served.** **Independent characterisation.** SPL is a spread-driven, import-substituting converter with near-monopoly domestic scale in PS. That status was reinforced in FY2021 when the second-largest producer's plant (LG Polymers, Visakhapatnam) shut after the May 2020 styrene leak. CRISIL notes that the second-largest player's plant closed in FY2021. SPL's moat rests on four things: scale; logistics proximity to West-India appliance clusters; a long-standing grade portfolio designed to counter low-priced imports; and conservative finances. Its weaknesses are total dependence on imported SM, heavy exposure to the Indian cooling-appliance cycle, and a historically thin specialty mix (SPC and XPS were about 6% of FY25 revenue, per CRISIL). The ABS, compounding (Xmold) and XPS expansions are the first credible move up the value curve, but execution in FY26 was uneven: ABS started six months late and then halted for an equipment failure.

Revenue$0.6B
Employees444
Market CapN/A
Founded1989
United States, North America
Sundow

Sundow Polymers Co., Ltd.

Premium
Information Technology

| Field | Detail | |---|---| | Entity profiled | Sundow Polymers Co., Ltd. (English trade name; Chinese registered name not confirmed in public English-language sources) | | Country | People's Republic of China | | Website | sundowpolymers.com (company-operated domain; page content could not be retrieved at time of writing) | | Group structure | "Sundow Group", including Sundow Polymers Co., Ltd. and Sundow Material Technology Co., Ltd. (established 2024) | | Listing status | Privately held, unlisted. No listing found on the Shanghai, Shenzhen, Beijing, Hong Kong or any foreign exchange. The "Public company" classification in the input list appears incorrect. | | Match confidence | High. Exact legal-name match; consistently identified across directories, customs data and market-research company lists as a Weifang, Shandong producer of chlorinated polymers. | ### Core identifiers | Field | Detail | Source | |---|---|---| | Legal name | Sundow Polymers Co., Ltd. | Knowde supplier store; Panjiva | | Former names | None identified | — | | Founding year | 2010 (company profile). The group says it has produced chlorinated polymers since 2012. A third-party directory states 1995, which conflicts and appears unreliable (see discrepancy note). | Knowde; IPF Bangladesh exhibitor release (20 Nov 2025); SpecialChem | | Incorporation jurisdiction | Shandong Province, PRC (inferred from HQ and plant location) | Knowde | | Headquarters | Weifang City, Shandong Province. Customs-record address: 8F, Renhe Mansion, No. 399, Economic Development Zone, Weifang, China | Knowde; Panjiva | | Production site | Weifang Binhai Chemical Park, a nationally approved chemical zone | Knowde | | Stock exchange / ticker | None (unlisted) | — | | ISIN / CUSIP | Not applicable | — | | Fiscal year end | NPD (PRC statutory default is 31 December) | — | | Employees (latest) | NPD | — | | Employees (3-year trend) | NPD | — | | Auditor | NPD | — | | Market capitalisation | Not applicable (unlisted) | — | | Registered capital | NPD | — | Sundow Polymers is a privately owned, mid-sized Chinese specialty-chemicals manufacturer based in Weifang, Shandong, the country's densest cluster of chlorinated-polymer producers. It makes chlorinated high polymers and PVC processing auxiliaries. Its main products are chlorinated polyethylene (CPE) used as an impact modifier and elastomer, chlorinated polyvinyl chloride (CPVC) resin and compounds for hot-water and industrial piping, high-chlorinated polyethylene (HCPE), chlorosulfonated polyethylene (CSM, sold as SUNPREN™), acrylic impact modifiers (AIM) and acrylic processing aids (ACR). The company is regularly listed by international market-research firms among the leading global CPE suppliers, alongside Weifang Yaxing, Shandong Gaoxin, Hangzhou Keli, Resonac and Dow. Its recent strategic direction is a move downstream into finished CPVC compounds through a dedicated subsidiary formed in 2024. This shifts the business toward higher-value, specification-driven piping materials and toward export markets such as South Asia and North America. --- ### Company self-description The company's supplier-store profile describes Sundow as a high-tech chemical enterprise that combines R&D, production, sales and technical service. It names chlorinated high polymers and PVC processing auxiliaries as its main products and cites technological innovation as the driver of portfolio optimisation (Knowde supplier store, undated). A Nov 2025 trade-fair release states that the group has concentrated on chlorinated polymers, mainly CPE and CPVC, since 2012. The same release says the group follows a "dual-drive" strategy built on quality and innovation (IPF Bangladesh exhibitor release, 20 Nov 2025). ### Independent characterisation | Revenue model component | Estimated relevance | Evidence | |---|---|---| | Product sales (resins, modifiers, compounds) | Primary / near-100% | All disclosed activity is manufacturing of polymers | | Services | Ancillary (technical support, pilot trials) | 2,000 m² R&D centre and pilot base (Nov 2025 release) | | Subscription | None identified | — | | Licensing | None identified | — | Sundow is a commodity-to-specialty intermediate chemicals producer. It sits in the middle of the chlor-alkali / polyolefin / PVC value chain. It buys high-density polyethylene (HDPE), PVC resin, chlorine and acrylic monomers, chemically modifies them by chlorination, chlorosulfonation or emulsion polymerisation, and sells modified polymers to compounders and converters. Its products are typically 3–15% of a customer's formulation, but they largely determine finished-product performance in impact strength, heat resistance, flame retardancy and weatherability. **Business model.** The business sells physical products almost entirely. Revenue comes from tonnage sales of resins, powders and compounds, mostly in 25 kg bags or jumbo bags. No subscription, licensing or service revenue is disclosed. Technical service, meaning formulation support and the pilot-scale extrusion and molding trials offered through its R&D centre, appears to be a sales enabler rather than a revenue line. ### Value-chain position | Stage | Participants | Sundow's role | |---|---|---| | Feedstocks | Chlor-alkali producers (chlorine), polyolefin producers (HDPE), PVC resin producers, acrylic monomer producers | Buyer | | Chlorination / modification | CPE, CPVC, HCPE, CSM producers | Core activity | | Additive formulation | AIM / ACR producers | Core activity | | Compounding | CPVC compounders, PVC dry-blend makers, rubber compounders | Expanding into (CPVC compounds, 2024+) | | Conversion | Pipe extruders, fitting moulders, profile and window makers, cable and hose makers | Customer base | | End use | Construction, plumbing, fire sprinklers, wire and cable, automotive, industrial | End markets | ### Customer types - **PVC profile, pipe and sheet converters**, which use CPE 135A-type impact modifiers, AIM and ACR. - **Rubber and cable compounders**, which use elastomer-grade CPE (CM), CSM and chloroprene grades for cable jackets, hoses, belts, seals and roofing membranes. - **CPVC pipe and fitting manufacturers**, which use CPVC resin and compounds for hot and cold water, fire sprinkler and industrial chemical piping. - **Coatings, adhesives and inks formulators**, which use HCPE and solvent-soluble CSM grades. - **Specialty distributors**, such as Harwick Standard Distribution Corporation in the United States (identified from customs records). ### End markets served | End market | Products | Demand driver | |---|---|---| | Building and construction (windows, doors, siding, pipes) | CPE, AIM, ACR, CPVC | Urbanisation, housing, water infrastructure | | Plumbing and fire protection | CPVC resin and compounds | Hot-water piping substitution of metal; sprinkler codes | | Wire and cable | CPE (CM), CSM, CR | Electrification, EVs, grid upgrades | | Automotive | CSM, CR, CPE | Hoses, seals, belts | | Industrial rubber goods | CR, CSM | Conveyor belts, rollers, transmission belts | | Coatings, adhesives | HCPE, CSM (solvent grades), CR | Anti-corrosion coatings, contact adhesives |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2010
Weifang, China
Sociedad

Sociedad Comercial del Plata S.A.

Premium
Information Technology

SCP is one of Argentina's oldest listed diversified holding companies. It is effectively a closed-end vehicle that allocates capital across four Argentine real-economy verticals: energy (downstream fuels and lubricants through DAPSA, plus a non-consolidated 22.3% economic stake in upstream and midstream producer CGC), construction materials (ceramics, porcelain tile, bricks and architectural glass through Canteras Cerro Negro), agro-industry and branded food (74.65% of listed Morixe Hermanos), and residual transport and real-estate positions. Its earnings are dominated by its equity-method share of CGC's results. Consolidated operating businesses run at thin margins and are exposed to Argentine construction and consumption cycles. The stated strategy is to own stakes of 50% or more so it controls management and capital allocation, to divest non-core assets, and to internationalise, chiefly through Morixe's regional food expansion. At the last verified price, SCP trades at roughly 0.47× attributable book value. This is a deep holding-company discount that reflects Argentine macro risk, governance opacity and volatile, CGC-driven earnings. --- **Company's own description.** In its filings, SCP describes itself as an Argentine holding company present in strategic sectors: agro-industry/food, construction, energy/oil and derivatives, transport, and real estate. Its principal activity is holding equity stakes in other companies. It began operating in 1927 and lists on BCBA/BYMA as COME (Reseña Q1-2025). The 2025 corporate presentation adds infrastructure to that list. **Business model.** SCP is a pure holding company at the parent level. Its separate (parent-only) balance sheet at 31-Mar-2026 shows ARS 621.6 bn of assets, of which ARS 610.2 bn are investments in subsidiaries and associates. Parent cash is only ARS 0.12 bn. Parent income comes from three sources: - equity-method results of investees; - management fees charged to subsidiaries (ARS 322 M in Q1-2026); - financial and FX results. Consolidated revenue comes almost entirely from the operating subsidiaries that SCP controls: There is no subscription or licensing revenue of consequence. A one-off exception was the brand-licence and contract-termination income from Lamb Weston (USD 13 M agreed in October 2024 and recognised partly in 2025). **Value-chain position.** **Energy:** DAPSA is a midstream/downstream marketer and logistician, not a refiner. It sources product (for example, a 5-year YPF supply contract signed in December 2024 and a Chevron agreement in January 2026) and sells it through its stations and distributors. CGC, by contrast, is an integrated upstream producer with gas-transport holdings. **Construction:** CCN is vertically integrated "from the quarry". It owns clay and raw-material quarries (Olavarría and Córdoba) feeding its own plants. **Food:** Morixe is a branded consumer-packaged-goods company. It runs its own mills and plants plus third-party co-manufacturers (15 establishments, owned and third-party), and its distribution reaches about 100,000 points of sale across Mercosur. **Customer types and end-markets.** - Fuel station operators and retail motorists in 17 provinces (central and northern Argentina). - Industrial lubricant users. - Construction distributors, builders and architects (residential and non-residential). - Supermarkets, wholesalers and food-service channels. - Export markets (USD 20 M+ of annual food exports at Morixe; Biomac sells organic frozen fruit to the US and Canada; Intertrópico distributes to more than 1,400 European customers). **Independent characterisation.** SCP's reported earnings are driven by commodity and FX swings through CGC. Underlying consolidated operations are low-margin: gross margin was 8.7% in both 9M-2025 and Q1-2026, and selling and administrative costs exceed gross profit (analyst-computed from interim FS). The group's economic value is therefore concentrated in three things: 1. the CGC stake, carried at ARS 166.3 bn including goodwill at 31-Mar-2026; 2. the Morixe stake, a listed and therefore observable value; 3. a large US-dollar treasury book (ARS 48.3 bn of US Treasuries consolidated at 31-Mar-2026).

RevenueN/A
Employees1,200
Market CapN/A
Founded1927
United States, North America
Sociedad

Sociedad Anonima Importadora y Exportadora de la Patagonia

Premium
Information Technology

La Anónima is Argentina's leading supermarket operator in the interior of the country and the dominant grocer of Patagonia, ranking as the fourth-largest food retailer nationally by sales and the second-largest under Argentine ownership. Founded in 1908 as a Patagonian trading house, it was rebuilt from 1978 by Federico Braun into a vertically integrated grocery platform comprising roughly 170–180 stores across more than 90 cities, a network of eleven distribution centres and fresh-produce hubs, two export-licensed beef plants (Salto, Buenos Aires; Speluzzi, La Pampa), a proprietary credit card (Tarjeta La Anónima, via Tarjetas del Mar), an e-commerce channel and a loyalty programme. Its strategic distinctiveness lies in serving small and mid-sized cities where multinational rivals are thin, supported by owned logistics and beef supply. The March 2026 acquisition of twelve Libertad hypermarkets marks a pivot from regional champion to national interior leader, executed against a backdrop of weak consumption and compressed margins. --- ### What the company does SAIEP is a food-retail-led group whose economic engine is the operation of supermarkets under the "La Anónima" banner. Around this core it has assembled a vertically integrated ecosystem: **Supermarkets:** neighbourhood and mid-size supermarkets, larger "compact hypermarket" formats (3,500–5,000 m² targeted for new and converted stores, per CEO Nicolás Braun in 2026), selling food, beverages, fresh produce, meat, bakery, household, personal care, baby products and a technology/home range online. **Meat processing ("frigoríficos"):** two bovine slaughter and packing plants that supply the store network (including centrally produced ground beef, chorizos and sausages sold under the La Anónima brand) and export premium beef, notably to the European Union under the Hilton quota. - **Consumer credit ("Administración de tarjeta de crédito propia")** — the Tarjeta La Anónima, launched in 2009 in partnership with Tarjetas del Mar S.A. (TDM), which the sustainability report treats as part of the reporting perimeter; the B Corp profile describes it as the group's fintech. **Real estate:** a small rental business (galleries/commercial space adjacent to stores), with property development under the direct oversight of the chairman since 2020. ### Company's own description The company's self-description (B Corp profile, 2025, paraphrased): La Anónima defines itself as synonymous with supermarket retailing in Patagonia and in small and mid-sized Argentine cities; the fourth retailer by national sales and the second of Argentine ownership; operating 169 branches in 10 provinces and 89 localities, 11 distribution centres, 1 transfer base, 3 fruit-and-vegetable consolidation centres, 1 slicing centre, 1 bakery centre, 2 meat plants, an e-commerce channel and a fintech, with more than 12,000 employees. Its stated purpose is to "bring a better future closer" to customers and communities, operationalised through a triple-impact (economic, social, environmental) decision framework. ### Business and revenue model | Revenue type | Description | Approx. share of FY2025 segment revenue | |---|---|---| | Product sales (retail) | Grocery and general merchandise sold in stores and online | ≈91% (Supermarkets segment) | | Product sales (industrial/wholesale & export) | Beef and by-products sold to third parties domestically and abroad | ≈8% (Meat Processing segment) | | Financial services | Card fees, financing income and related charges on Tarjeta La Anónima | ≈0.5% | | Rental/licensing | Real-estate rental income | ≈0.1% | | Subscription | None identified | 0% | Source: S&P Global MI segment data, FY2025 (ARS 2.55 trillion total in June-2025 pesos). Percentages derived. ### Value-chain position La Anónima spans upstream (cattle purchasing and slaughter; centralised meat elaboration; bakery and slicing centres), midstream (owned regional distribution network sized for long Patagonian distances), and downstream (store retail, e-commerce, loyalty and consumer credit). It is a price-taker on most branded grocery categories but captures margin through private label (more than 1,000 SKUs under "La Anónima" and "Best", per Cadena 3, June 2026), fresh categories and in-house beef. ### Customer types and end-markets **Retail households:** in Patagonian provinces (Río Negro, Neuquén, Chubut, Santa Cruz, Tierra del Fuego, La Pampa) and, increasingly, in central and northern provinces (Buenos Aires interior, Santa Fe, Córdoba, Chaco, Santiago del Estero, Tucumán, Salta, San Juan, Misiones). **Export beef buyers:** in the EU and other markets (Germany, England/UK, Italy, Belgium, Portugal, France, Netherlands, Switzerland per Bichos de Campo), kosher product to Israel and meat by-products (meal, bone, blood products) to China (Letra P). **Domestic meat trade:** customers (third-party butchers/distributors). **Consumer-credit users:** of the store card. **Public-sector buyers:** (provincial governments have historically purchased from the chain; Tierra del Fuego publicly announced it would stop doing so in June 2022). ### Independent characterisation Analytically, SAIEP is a low-margin, high-asset-turnover regional grocer with an unusually high degree of vertical integration for its size and a structurally defensible footprint in sparsely populated, logistics-intensive markets. Its operating margin has oscillated between roughly 0.6% and 1.9% in FY2022–FY2026, meaning that in high-inflation years financial and monetary-exposure results have frequently mattered as much as trading profit. The firm is now attempting a scale step-change — doubling the population it serves from roughly 5 million to 10 million people, per management — at a time when Argentine supermarket volumes are weak and consumer credit delinquency has spiked.

RevenueN/A
Employees12,000
Market CapN/A
Founded1908
United States, North America
PI

PI Advanced Materials Co., Ltd.

Premium
Information Technology

PI Advanced Materials is the world's largest maker of polyimide (PI) film by capacity and market share. Arkema puts its share above 30%, and Korean press put its capacity at roughly 1.5 times that of the number-two producer. PI film is a "super engineering plastic." It keeps its mechanical and dielectric properties across an extreme temperature range, roughly −269 °C to +400 °C, which makes it hard to substitute in flexible printed circuit boards (FPCB), smartphone graphite heat-dissipation sheets, EV battery and motor insulation, semiconductor process tapes, displays and aerospace. Born from the 2008 merger of SKC's and Kolon's PI units, the company passed through private-equity ownership (Glenwood, 2020–2023) before Arkema bought control. That makes PIAM the Asian polyimide platform inside a global specialty-materials group. Its investment case now rests on mix upgrading toward ultra-thin FPCB films for slim and foldable smartphones, plus diversification into "Advanced Industrials" (EV, semiconductor, robotics, aerospace) through Arkema's Western sales channels. --- **What the company does.** PIAM makes and sells polyimide-based materials. Its core product is PI film, cast from polyamic acid made from aromatic dianhydrides (mainly PMDA) and diamines (mainly ODA) in solvent (DMF or DMAc), then imidised and tentered. It also sells PI varnish (liquid polyimide precursor), PI powder, and moulded or preformed PI parts. Simply Wall St's company description lists PI film, PI varnish, and powder/mould products for IT, electric vehicles, display, semiconductor and advanced industrial uses. **Company's own framing (from IR releases).** Each quarterly release presents PIAM as Korea's PI materials specialist holding the number-one global market share. Revenue is reported by application: **FPCB films:** (base film for flexible copper-clad laminates and coverlay in smartphones, tablets and wearables) **Heat-dissipation sheet films:** (PI film carbonised and graphitised by customers into synthetic graphite sheets for smartphone and device thermal management) **Advanced Industrials:** (EV battery insulation films, EV motor/wire varnish, semiconductor and industrial tapes, display, aerospace and other industrial uses) Management's medium-term framing, stated in 2024, was to lift the non-film / Advanced Industrials share to 20% or more of sales while sustaining an EBITDA margin of 30% or more. **Business model.** Pure product manufacturing on a business-to-business basis. Revenue comes almost entirely from product sales. There is no material service, subscription or licensing revenue (Butler.works classifies 100% of 2Q26 sales as "PI film"). Pricing follows a mix of long-term supply agreements and negotiated spot pricing. One example: the heat-dissipation business recovered in 2Q24 after a long-term supply agreement with a key customer normalised orders. Margins depend heavily on three things: **Utilisation:** PI film is capital-intensive with high fixed costs. Utilisation swung from above 90% (2021) to 43.5% (FY2023), and was 56.6% in 2Q26. **Raw-material spreads:** PMDA, ODA and DMF prices matter. **Mix:** Ultra-thin FPCB film reportedly sells at about three times the ASP of conventional grades (Meritz, May 2025). **Value-chain position.** PIAM sits in the middle of the value chain. Upstream are petrochemical intermediates suppliers (PMDA/ODA/solvents). PIAM's direct customers are FCCL and coverlay makers, graphite-sheet converters, battery/module and motor makers, and tape converters. The ultimate demand drivers are smartphone OEMs (including a North American OEM and Chinese OEMs), EV and battery makers, and semiconductor and industrial equipment makers. **Customer types and end-markets.** **Independent characterisation.** PIAM is best understood as a high-operating-leverage, single-chemistry specialty film producer. Its earnings are dominated by the consumer-electronics cycle, with roughly three-quarters of sales historically tied to smartphones through FPCB and heat-dissipation films. Its strategic task since 2023 has been to cut cyclicality by moving up the mix curve (ultra-thin, high-performance grades) and by using Arkema's global network to grow industrial, EV and aerospace volumes. The 1H26 results suggest the mix lever is working: gross margin rose to 37.1% from 29.1% in 1H25. The volume lever has not yet delivered, with utilisation still in the mid-50s.

Revenue$0.2B
Employees320
Market CapN/A
Founded2008
United States, North America
Sinopec

Sinopec Shanghai Petrochemical Company Limited

Premium
Information Technology

SPC is one of China's oldest large-scale integrated refining and petrochemical complexes. It operates a single mega-site at Jinshanwei on the Hangzhou Bay coast of Shanghai, with roughly 16 Mtpa of crude distillation capacity and about 700 ktpa of ethylene capacity (company website as cited by Reuters, June 2022). It processed 12.61 Mt of crude in FY2025. Petroleum products generate about 63% of IFRS net sales, chemicals about 27% and trading about 10%. The company is commercially embedded in the Sinopec system. Sinopec Group and its affiliates took 72% of FY2025 turnover as the largest customer and supplied 49.6% of purchases as the largest supplier. Strategically, SPC is trying to move from a commoditised refiner, loss-making in three of the last five years, toward a "refining-to-chemicals, chemicals-to-materials" model. Large-tow carbon fibre, polyolefin specialties and elastomers are the spearheads, underpinned by an RMB19.6bn site-wide technological transformation programme. It carries a net cash balance sheet but generates thin, volatile margins. --- ### Company's own description (FY2025 Annual Results) SPC describes itself as a highly integrated petrochemical enterprise located at Jinshanwei in south-west Shanghai. Through crude oil processing, it mainly produces a broad range of petroleum products, intermediate petrochemicals, resins and plastics, and synthetic fibres. Most of its products are sold in the domestic PRC market, chiefly to customers in Eastern China. The company says it leverages refining-chemical integration to optimise its product mix and develop new products. It cites three core competitive advantages: quality, location in the Yangtze River Delta, and vertical integration. It notes more than 50 years of operating experience, self-owned utilities and environmental systems, and sea, inland-waterway, rail and road logistics (2026 Interim, s.3.2.4). ### Independent characterisation SPC is a captive, mid-scale, coastal brownfield refinery-cracker complex whose economics are set by three spreads: - The refining margin. This is constrained by NDRC guidance pricing for gasoline and diesel and by heavy consumption tax. - The naphtha-to-olefins and aromatics chain margin. This has been structurally negative since 2022 because of Chinese capacity additions. - Crude cost. More than 95% of crude is imported, and crude was 70.5% of FY2025 CAS operating cost. Its business model is almost entirely product sales: volume multiplied by price. There are minor service revenues from storage and transport, steam and utilities, property leasing, technology R&D services to Sinopec Corp. (RMB112.6M in FY2025), and personnel secondment. There is no subscription or licensing revenue of significance. The company states it does not depend on any patent or licence in a material respect (FY2025 MD&A, s.5.3.2.C). **Value-chain position.** SPC sits midstream. It buys crude and some naphtha and feedstock mainly through Sinopec channels (Unipec and Sinopec Group) and a few third parties (Sinochem Oil, CNOOC East China Sea gas). It sells: - road and aviation fuels, largely to Sinopec Corp.'s marketing arm, which is mandated for many refined products; - aromatics and olefin derivatives to downstream converters (for example Zhejiang Dushan Energy, Jiaxing Petrochemical, Zhejiang Baling Hengyi Caprolactam, and the associate Shanghai SECCO); - specialty polymers and carbon fibre to industrial end users such as wind, cable, medical and pressure-vessel makers. **Customer types.** 1. Sinopec Corp. marketing and chemical-sales subsidiaries, which take the dominant share. 2. Regional petrochemical converters in Zhejiang, Jiangsu and Shanghai. 3. Polymer processors and fabricators. 4. Aviation fuel off-takers in Shanghai. 5. Export customers, at 2.8% of FY2025 principal revenue. **End markets.** Road transport fuels, aviation (Shanghai international air-hub positioning), marine bunker fuel, polyester and textile chains (via PX and EG), packaging, cable and wire, medical packaging, wind-power composites, and pressure vessels including hydrogen and CNG tanks. ### Revenue model mix (FY2025, IFRS net sales) | Revenue type | RMB M | % of net sales | Nature | |---|---|---|---| | Petroleum products | 40,053.47 | 62.58 | Product sales; partly regulated prices | | Chemical products | 16,971.61 | 26.51 | Product sales; market prices | | Trading of petrochemical products | 6,365.37 | 9.94 | Merchant trading, near-zero margin | | Others (services, utilities, leasing) | 617.80 | 0.97 | Services and other | | Total | 64,008.25 | 100.00 | — | Source: FY2025 Annual Results Announcement, s.5.3.1.

RevenueN/A
Employees6,698
Market CapN/A
Founded1972
United States, North America
Shandong

Shandong Rainwell New Materials Technology Co., Ltd.

Premium
Information Technology

Shandong Rainwell is a specialist Chinese manufacturer of polymer additives, founded in 2003 and based in the Zibo High-tech Zone, one of China's largest petrochemical and polyolefin clusters. Its core competence is nucleating and clarifying agents for polypropylene (PP), the additives that raise crystallization temperature, stiffness and heat-deflection temperature, shorten moulding cycle times and, in the clarifier grades, reduce haze. Around this core it has built an adjacent portfolio of hindered-phenol antioxidants, light stabilizers, fluoropolymer processing aids, calcium stearate and custom compacted "one-pack" additive preblends. The company describes itself as one of China's largest and most technically advanced nucleating-agent production bases. It is approved in the supplier networks of Sinopec and CNPC, and a 2021 industry survey named it as one of four principal domestic nucleating-agent producers alongside GCH Technology, Yantai Zhichu and Guangdong Winner. Its strategic proposition is import substitution: supplying Chinese resin producers and compounders with domestically made alternatives to products from Milliken, Adeka and BASF. --- ### Company's own description The company presents itself as a high-tech enterprise that combines R&D and production. It focuses on nucleating agents, light stabilizers, antioxidants, fluoropolymer processing aids and various compounded, granulated additive packages, and it offers customized solutions to the chemical and plastics industries. It says it has concentrated on nucleating-agent solutions for polypropylene since its founding, and that its products are used by China Sinopec Group and by overseas petrochemical producers (website, About Us; undated, live as of October 2026). The company also states that its integrated production of key intermediates and finished products is a competitive advantage. This implies backward integration into at least some precursor chemistries, such as substituted sorbitol acetal intermediates or phosphate-ester intermediates. The TÜV certificate scope independently confirms that the company develops and manufactures "intermediates" alongside finished nucleating agents, antioxidants, light stabilizers and fluoropolymer additives. ### Independent characterization | Stage | Participants | Rainwell role | |---|---|---| | Basic petrochemicals and fine-chemical feedstocks (phenols, sorbitol, benzaldehydes, phosphorus chemicals, aluminium/sodium salts) | Chemical majors and traders | Buyer | | Additive intermediates | Integrated additive makers | Producer (per certificate scope) | | Additive actives (nucleators, clarifiers, AOs, HALS/UV, PPA) | Milliken, Adeka, BASF, Songwon, GCH, Rianlon, Rainwell, etc. | Core producer | | Additive preblends / one-packs | Additive makers, specialist blenders | Producer (Max-B preblends) | | Polyolefin resin production (in-reactor additivation) | Sinopec, PetroChina/CNPC, private refiners and PDH operators | Customer | | Compounding / masterbatch | Compounders and masterbatch houses | Customer | | Converters (injection moulding, thermoforming, film, tape, pipe) | Packaging, automotive, appliance, medical | End-users | Rainwell is a B2B specialty-chemicals producer in the "functional polymer additives" niche. Its revenue model is almost entirely product sales: kilogram- and tonne-scale shipments of powders, granules and compacted preblends. A secondary formulation-service element appears in its "Customized Solution" offering, where blend formulas are built to customer specification. There is no evidence of licensing, subscription or recurring-service revenue. **Value-chain position.** **Customer types.** 1. **State-owned and private polyolefin producers** that add nucleators, clarifiers and stabilizer packages at the pelletizing stage to make "nucleated", "clarified" or "high-crystallinity" PP grades. Sinopec and CNPC network qualification is the anchor evidence. 2. **Compounders and masterbatch producers** making modified PP for automotive and appliance applications. 3. **Overseas petrochemical customers**. The company cites them generically; trade data show exports to Vietnam. 4. **Traders and distributors**, inferred from the e-business channel listed on the website. **End-markets served (via customers).** These are rigid packaging and thin-wall injection moulding, transparent housewares and food containers (clarified PP), medical devices such as syringes and labware, automotive interior and under-hood PP compounds, household appliances, PP pipe (β-nucleation is a typical route for PP-R pipe, though Rainwell does not list a β-nucleator), and PP tape/raffia (the RY 330 antioxidant is positioned for tape extrusion). **Revenue mix (product vs. service vs. subscription vs. licensing).** Not publicly disclosed. [Analyst inference] Nearly all revenue is likely product sales, with nucleating and clarifying agents the largest category given the company's stated focus.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2003
Shandong, China
Shandong

Shandong Hongxin Chemical Co., Ltd.

Premium
Information Technology

| Similarly named entity | Location | Business | Why excluded | |---|---|---|---| | Zhengzhou Hongxin Chemical Co., Ltd. | Zhengzhou, Henan | Drilling-fluid filtration reducers | Not in Shandong | | Hubei Hongxin Chemical | Wuxue, Hubei | Optical brighteners | Not in Shandong | | Nantong Hongxin Chemical Co., Ltd. | Nantong, Jiangsu | Chemical trading; connected to Nantong Acetic Acid Chemical | Not in Shandong; a distributor | | Hongxin Chemical Co, Ltd | Puyang, Henan | Small chemical exporter | Not in Shandong | | China Chemical Corp. (CHCC) | Zhoucun District, Zibo, Shandong | Phthalic anhydride (PA) and maleic anhydride (MAH) | Different legal entity with a different name. It is in the same district with the same products, so the two are easily confused [YAHOO-CHCC] | No company is registered under the exact English name "Shandong Hongxin Chemical Co., Ltd." in an English-language registry. The best match is 山东宏信化工股份有限公司. It is an active Shandong chemical producer, and a commodity-market report refers to it in English by exactly this name [SUNSIRS-2024]. Several other Chinese companies use the "Hongxin Chemical" name, and they are a frequent source of data errors. The dossier does not profile them: ### Snapshot table | Field | Value | Source | |---|---|---| | Legal name (Chinese) | 山东宏信化工股份有限公司 | [CNPP], [MAIGOO] | | Legal name (English, as used in market reports) | Shandong Hongxin Chemical Co., Ltd. | [SUNSIRS-2024] | | Brand / short name | 宏信化工 ("Hongxin Chemical") | [CNPP] | | Former names | Not publicly disclosed. The company was formed by promoters that included the Zhoucun Organic Chemical Plant of Zibo; see Section 3 | [CNPP] | | Founding / incorporation date | 14 October 1996 | [MAIGOO] | | Unified Social Credit Code | 91370300613293918A | [MAIGOO] | | Legal form | "Other joint-stock company (unlisted)" (其他股份有限公司(非上市)) | [MAIGOO], [CNPP] | | Registration status | Active (在营企业) | [MAIGOO] | | Registration authority | Zibo Administration for Market Regulation | [MAIGOO] | | Latest registry approval date | 1 March 2022 | [MAIGOO] | | Licence term | Indefinite from 14 Oct 1996 | [MAIGOO] | | Registered capital | RMB 218.00 million | [MAIGOO], [CNPP] | | Legal representative | Zou Fangping (邹方平) | [CNPP] | | Headquarters address | No. 10 Xinjian West Road, Zhoucun District, Zibo, Shandong Province, PRC | [CNPP], [MAIGOO] | | Telephone | +86 533 6239888 | [CNPP] | | Website | No official website could be found. Directories list the website field as blank | [MAIGOO] | | Stock exchange / ticker | None. The company is unlisted. No listing on SSE, SZSE, BSE, NEEQ or HKEX was found | [MAIGOO] (legal form) | | ISIN / CUSIP | Not applicable (unlisted) | — | | Fiscal year end | 31 December (statutory PRC calendar year; the company's own disclosure was not found) | PRC Accounting Law | | Employees (latest and 3-year trend) | Not publicly disclosed | — | | Auditor | Not publicly disclosed | — | | Market capitalisation | Not applicable. The company is unlisted and has no public price | — | | Total assets (self-reported, undated) | About RMB 800 million | [CNPP] | | Listed status vs. input list | The input list says "Public company". The entity is actually an unlisted joint-stock company (股份有限公司). In Chinese corporate law a "joint-stock company" can have many shareholders, but it is not publicly traded unless it lists. This difference is probably why it was classified as "public" | Analyst note | Shandong Hongxin Chemical is a mid-sized, unlisted, privately run joint-stock producer of basic organic chemical intermediates and their derivatives. It is based in Zhoucun District of Zibo, one of China's oldest petrochemical clusters. Its core product is phthalic anhydride (PA). The company converts PA into phthalate and other ester plasticizers and also makes unsaturated polyester resin (UPR), maleic anhydride (MAH) and PVC disposable gloves. This creates a short, vertically linked chain: o-xylene or naphthalene → PA → plasticizers/UPR → PVC gloves. Directory profiles put stated nameplate capacity at 260 kt/yr PA and 250 kt/yr plasticizers, which the company describes as among the largest in China. A 2024 market report, however, cited 180 kt/yr PA capacity. The company is recognised as a drafter of the Chinese national standard for industrial dibutyl phthalate (GB/T 11405-2006). Third-party brand directories place it among China's ten best-known plasticizer brands. The company does not publish financial statements, so it remains a largely opaque, commodity-exposed regional player. --- ### Company's own description (paraphrased and translated) No annual report exists. The best available self-description comes from the corporate profile that brand directories republish [CNPP], [MAIGOO]. In paraphrase, it says the following: - The company was jointly promoted by the Zhoucun Organic Chemical Plant of Zibo, Shandong Junfeng Industrial Co., Zibo Hua'an Chemical Co., the Beijing Research Institute of Chemical Industry (北京化工研究院) and the technology company of Qingdao University of Science and Technology. - It mainly produces basic organic chemical raw materials. It has five product series (phthalic anhydride, plasticizers, unsaturated polyester resin, maleic anhydride and plastic gloves) covering about 30 grades. - It states nameplate capacities of 260 kt/yr PA and 250 kt/yr plasticizers, which it describes as near the top in China; 100 kt/yr UPR; 60 kt/yr MAH; and 2.4 billion pieces/yr of PVC gloves. - Its supporting environmental and energy assets are a regenerative thermal incinerator for MAH tail gas, a wastewater treatment plant handling 1,000 t/day, and a 4,500 kW waste-heat power generation unit. - It describes its development path as low-cost expansion, specialisation and continuous product-structure adjustment, and claims advantages in capital, cost and people. ### Independent characterisation | Value-chain stage | Inputs / outputs | Hongxin's role | |---|---|---| | Upstream feedstock | o-xylene (from refineries/reformers) and industrial naphthalene (from coal-tar processing) | Buyer. The company owns no refinery or coking assets (none disclosed) | | Intermediate | Phthalic anhydride (PA), maleic anhydride (MAH) | Core producer | | Derivative | Phthalate/ester plasticizers (e.g., DBP, DOP/DEHP-type, others not itemised), UPR | Producer. PA and MAH are captively consumed | | Converted products | PVC disposable gloves | Producer. This consumes the company's own plasticizer | | End markets | Flexible PVC (cable, film, flooring, leather, gloves), fibreglass-reinforced plastics, coatings/alkyds | Sells to converters and distributors | From the product slate and stated capacities, Hongxin is best described as an integrated PA-chain processor. It sits in the midstream of the aromatic value chain: **Revenue model.** Revenue comes almost entirely from product sales of bulk chemicals, priced off spot and contract commodity benchmarks. No service, subscription or licensing revenue has been disclosed. Pricing is commodity-linked: PA is quoted daily in RMB/tonne, separately for o-xylene-route and naphthalene-route material [SUNSIRS-2024]. Margins therefore depend mainly on the spread between PA and its feedstock and between plasticizer and PA plus alcohol. **Customer types.** PVC compounders, cable and wire makers, artificial-leather and film producers, FRP/composite fabricators (for UPR), coatings formulators, and glove distributors and importers. These are inferred from the product uses, because no named customers have been disclosed. **Product mix share.** The revenue split across PA, plasticizers, UPR, MAH and gloves is not publicly disclosed.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1996
Shandong Province, China
Polyvel

Polyvel Inc.

Premium
Information Technology

Polyvel, Inc. is a small, privately owned U.S. specialty chemicals-for-plastics company that converts difficult functional additives — liquids, low-melting-point solids, volatile and heat-sensitive chemistries, and organic peroxides — into free-flowing pelletised masterbatches that plastics processors can dose directly at the extruder or moulding machine. Operating from a single plant in Hammonton, New Jersey, and selling into Europe through its exclusive distributor Polyvel Europe GmbH near Hamburg, the company occupies a niche between global masterbatch majors and raw-additive producers. Its best-known franchise is peroxide "melt-flow" masterbatch for polypropylene visbreaking and PE/EVA crosslinking, supplemented by nonwoven softening, hydrophilic and electret-charge additives, antifogs, antistats, process aids (including the PFAS-free PureBlend line), PLA masterbatches, and a recycling-oriented portfolio (ReVal, rBOOST). Polyvel also sells toll and contract compounding capacity. Its competitive pitch rests on rapid development lead-times, custom formulation, and responsiveness rather than scale. --- ### The company's own description On its About Us page (last modified December 2024), Polyvel describes itself as founded in 1982 to design and produce specialty additive masterbatches and custom compounds for numerous thermoplastics applications, and states that, alongside developing functional additives, it is a fully capable toller. It cites end-uses in packaging, recycling, nonwovens, injection moulding, blow moulding, automotive and medical applications, and highlights its "Rapid Response" lead-times. The company frames its operating philosophy around four values — customers, people, innovation and continuous improvement — and a cultural code of 33 "Fundamentals" known internally as "The Polyvel Way." An older, widely syndicated corporate description (reproduced on Knowde and ScrapMonster) describes a technology-based, market-driven manufacturer serving the film, fiber, molding and compounding industries, operating from a 45,000 sq. ft. facility with six production twin-screw extrusion lines and two pilot-scale twin-screw extruders, and with a primary focus on liquid, low-melting-point, highly volatile and heat-sensitive additives. That description is undated; given that the company added two lines in 2018, the "six lines" figure may reflect the post-2018 configuration or an earlier one — this cannot be confirmed. ### Independent characterisation Polyvel is best characterised as a niche additive concentrate formulator and compounder. Its value-add is process know-how: encapsulating chemistries that are hazardous, messy or hard to meter (e.g., organic peroxides, liquid surfactants, fragrances, silicone fluids, glycerol monostearate) into a polymer carrier at controlled loadings so that downstream converters avoid handling liquids or powders. This is a classic "let-down" masterbatch business model: the customer buys a concentrate and dilutes it into virgin or recycled resin at a low percentage. ### Business and revenue model | Revenue stream | Description | Disclosed share of revenue | |---|---|---| | Proprietary additive masterbatches (product sales) | Catalogue grades sold by weight under Polyvel brands (Polyflow, PureBlend, SoftBatch, StabilPure, rBOOST, ReVal and coded grades) | Not publicly disclosed | | Custom formulations / custom compounds (product sales) | Customer-specific additive packages and full compounds developed by the technical team | Not publicly disclosed | | Toll and contract compounding (service) | Processing customer-owned materials on Polyvel extruders; may include customer-funded capital additions and dedicated capacity allocation | Not publicly disclosed | | Subscription / licensing | None identified | — | ### Value-chain position Upstream suppliers are additive chemical producers (peroxide, antioxidant, surfactant, fluoropolymer-alternative and silicone makers) and resin producers supplying carrier polymers (PP, PE/LDPE, EVA, PS, PLA, PET, PA, ABS, HIPS, PC per SpecialChem/UL Prospector product listings). Polyvel sits in the midstream as formulator/compounder. Downstream customers are plastics processors — film extruders, nonwoven (spunbond/meltblown) producers, injection and blow moulders, sheet thermoformers, foam extruders, compounders and recyclers — who in turn supply brand owners in packaging, hygiene, medical, automotive and consumer goods. ### Customer types and end-markets The homepage lists recycling, flexible packaging, rigid packaging, medical devices, nonwovens, film/sheet, foamed products, injection moulding and blow moulding as served markets. The Nonwovens Industry International Buyers' Guide profile adds sheet, compounding and reprocessing/recycling and notes global distribution. Hygiene (baby care, feminine care) and medical nonwovens are explicitly cited in the May 2025 softening-masterbatch release. Named customers are not publicly disclosed.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1982
NJ, US
Polledo

Polledo Sociedad Anonima, Industrial, Constructora y Financiera

Premium
Information Technology

Polledo S.A.I.C. y F. is a 1934-vintage Argentine construction and infrastructure-concession holding company that is now, in substance, a dormant listed shell within Grupo Roggio. Grupo Roggio is the Córdoba-based family conglomerate whose operating flagship is Benito Roggio e Hijos. Polledo's historical franchise was built through its affiliate Coviares S.A., concessionaire of the Buenos Aires–La Plata Autopista, the Ribereña of the Federal Capital and the New Bridge over the Riachuelo. A second affiliate, Covimet S.A., was linked to the northern stretch of Autopista 9 de Julio. The Buenos Aires province rescinded the Coviares concession "for exclusive fault of the concessionaire" in July 2013 and handed operation to the state-owned AUBASA. Since then Polledo has reported no meaningful revenue, persistent operating losses and deeply negative shareholders' equity of ARS -505M at FY2025. Its residual equity value, if any, rests on legacy claims and investments, possible group restructuring, and speculative retail trading in a thinly-floated stock. It does not rest on any operating business. --- ### Company's own description No current English-language annual report was retrievable. The descriptions syndicated by data vendors are derived from the company's filings and are summarized here. - **S&P Global Market Intelligence (via StockAnalysis, updated Aug 2026).** Polledo, through subsidiaries, engages in the construction, operation and maintenance of highways in Argentina. It is associated with the Ribereña de la Capital Federal and the New Bridge over the Riachuelo projects. It is a subsidiary of Roggio S.A. **Musaffa (vendor profile drawing on filings):** - Wholly-owned subsidiaries: - **Catastros y Relevamientos S.A. (Catrel S.A.)**, which provides territorial administration and tax-collection services. - **Polledo do Brasil Concessões e Investimentos Ltda.**, with operations established in Brazil. - Affiliates: - **Coviares S.A.**, for the construction and operation of the La Plata–Buenos Aires highway, the Ribereña and the Nuevo Puente over the Riachuelo. - **Covimet S.A.**, for the construction, conservation and operation of the northern stretch of Autopista 9 de Julio. - Minor stakes in Lismore International S.A., Benito Roggio e Hijos S.A. and Comsa S.A., among others. **EMIS (profile updated 10 Nov 2025):** EMIS describes Polledo as a listed Argentine construction and engineering company focused on highway, bridge and public-infrastructure development through subsidiaries and affiliates. It lists Catrel and Polledo do Brasil as subsidiaries. ### Independent characterization Based on the reported financials, Polledo is today a non-operating holding entity. The evidence is as follows: **No revenue:** S&P Global MI presents no revenue line for FY2021–FY2025 or TTM June 2026, and TradingView reports no revenue data. **Expenses are almost entirely overhead:** Operating expenses consist almost entirely of selling, general and administrative costs of ARS 133.28M in FY2025, plus small other operating expenses of ARS 3.10M. **No investment activity:** Capital expenditure is nil: free cash flow equals operating cash flow in every year reported. **Profit comes from non-operating items:** Reported profits in FY2021–FY2024 arose entirely from "other non-operating income". This peaked at ARS 513.54M in FY2023. - In an IAS 29 hyperinflationary context, an entity carrying large net monetary liabilities records a monetary-position gain (RECPAM) when inflation erodes those liabilities in real terms. - The size and timing of these gains is consistent with a RECPAM gain on Polledo's large peso-denominated liabilities: ARS 382–467M of "other long-term liabilities" over FY2023–FY2025. - The gains tracked Argentine inflation, which peaked in 2023 and decelerated in 2024–2025. - **This is an analyst inference; the line-item composition is not publicly disclosed in sources reviewed.** **Negative equity:** The equity deficit has persisted since at least FY2021 (ARS -190.47M) and widened to ARS -504.57M at FY2025 and ARS -546.15M at March 2026. **Funding comes from outside cash:** The company has no financial debt per S&P. Cash and equivalents never exceeded ARS 4.46M over five years, yet operating cash outflows were ARS 167–232M per year in FY2023–FY2025. Operations therefore appear to be funded by growth in payables and long-term liabilities, most plausibly to related parties within Grupo Roggio (inference). ### Business model and revenue model | Dimension | Assessment | |---|---| | Product vs service vs subscription vs licensing mix | Historically 100% services: construction, toll-road concession operation and maintenance, cadastral/tax-collection services via Catrel. Currently no reported revenue. | | Value-chain position | Historically a concession sponsor / equity holder (SPV shareholder) and EPC contractor; currently a holding company of legacy equity interests and claims | | Customer types | Historically: toll-road users (B2C via tolls); national, provincial and municipal governments (concession grantors, public-works clients; Catrel's tax-collection clients) | | End-markets | Argentine road infrastructure and urban motorways; municipal/territorial tax administration; Brazil concessions (via Polledo do Brasil, scale not publicly disclosed) | | Current economic engine | None operating; P&L is driven by non-operating items (likely inflation-adjustment gains/losses) and equity-method results (FY2025: ARS -1.91M) |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1934
Piso, Argentina
PMC

PMC Group Inc.

Premium
Information Technology

PMC Group is a founder-owned, acquisition-built US specialty chemicals and pharmaceutical-manufacturing conglomerate headquartered in Mount Laurel, New Jersey. Since 1994 it has assembled more than twenty carve-outs from global chemical majors – including PPG, BASF, ExxonMobil, ICI, Nova Chemicals, Chemtura, Arkema, Dow, AkzoNobel and Lanxess – typically acquiring non-core, mature niche product lines and repositioning them under PMC brands. Today the group describes itself as a global manufacturer of intermediate chemicals for industrial and specialty markets [S1], organized into nine business units: organotin stabilizers and catalysts (PMC Organometallix), renewable-based oleochemical derivatives (PMC Biogenix), defoamers and wax emulsions (PMC Crystal), flame-retardant and additive masterbatches (PMC Polymer Products), specialty esters (PMC Ouvrie), rubber chemicals in India, pharmaceutical CDMO services in France (PMC Isochem) and India, and nitroglycerin/energetic materials (Copperhead Chemical). Its competitive model rests on niche leadership, owner-operator decision speed and opportunistic portfolio rotation rather than scale. --- ### Company's own description On its current website, PMC Group characterizes itself as a global manufacturer of intermediate chemicals serving a broad range of industrial and specialty markets, emphasizing technical expertise, operational reliability, consistent quality and dependable supply; its tagline is "Technical Expertise. Reliable Supply. Proven Performance." [S1]. Earlier press-release boilerplate (2019–2021) described PMC as a US-based, growth-oriented, diversified global chemicals and pharmaceuticals company serving plastics, consumer products, electronics, coatings, packaging, mining, personal care, food, automotive and pharmaceuticals, built on growth through innovation while promoting social good [S3][S8]. The April 2026 boilerplate adds that PMC sources over half of its raw materials from renewable feedstocks [S19]. The shift in self-description – from "growth-oriented diversified chemicals and pharmaceuticals company" (2019–2021) to "global manufacturer of intermediate chemicals" with a reliability-of-supply message (2025–2026) – is analytically meaningful: it coincides with retrenchment (Memphis closure, exit from commodity fatty acids) and a website redesign, and suggests management is emphasizing supply security and operational dependability over expansionary diversification. ### Independent characterization PMC Group is best understood as a private, family-controlled roll-up of corporate carve-outs in mature, niche chemistries. The business model has three recurring features: 1. **Carve-out acquisition from majors.** Of the 24 dated milestones on the company's history page, 20 are acquisitions, and almost all are divisions divested by large multinationals (BASF ×3, Arkema ×2, PPG, ExxonMobil, ICI, Nova, Chemtura, Dow, AkzoNobel, Lanxess, Ecolab, Nexen, Isochem/Aurelius) [S2]. Purchase prices have consistently been undisclosed. 2. **Niche concentration.** Several units occupy small, consolidated global markets: organotin PVC heat stabilizers and tin catalysts (where the 2012–2013 Arkema and Dow deals gave PMC "a large share" of the world tin PVC stabilizer market, per the International Tin Association [S11]); fatty primary amides (Armoslip®, Kemamide®); and pharmaceutical-grade nitroglycerin, where Copperhead has been described as the sole US manufacturer of FDA-approved nitroglycerin for over 70 years [S8][S9]. 3. **Asset rationalization after acquisition.** PMC routinely restructures acquired footprints – e.g., relocating Lanxess organotin production from Bergkamen, Germany to Axis, Alabama and Carrollton, Kentucky (2020–2022) [S10], and closing the legacy Memphis oleochemicals plant (April 2026) after shifting amide capacity to South Korea [S12][S16]. ### Revenue model | Revenue type | Share of revenue | Description | |---|---|---| | Product sales (specialty/intermediate chemicals) | Not publicly disclosed (assessed as the large majority) | Organotin stabilizers/catalysts, fatty amides/esters, metallic stearates, defoamers, wax emulsions, masterbatches, specialty esters, rubber chemicals | | Pharmaceutical products (APIs, intermediates, excipients, bulk drug substance) | Not publicly disclosed | PMC Isochem (France), PMC YM-Pharma / PMC Pharmaceuticals India, Copperhead (nitroglycerin bulk drug substance listed with FDA as bulk ingredient [S26][S27]) | | Contract/custom manufacturing services (CDMO) | Not publicly disclosed | Custom synthesis, process development, scale-up at PMC Isochem; custom dosage-form manufacturing at Copperhead [S6][S9] | | Defense energetic materials | Not publicly disclosed | Copperhead supplies energetic chemicals (explosives and propellants) to the defense sector [S8][S31] | | Licensing / subscription | None disclosed | – | ### Value-chain position PMC sits in the mid-stream intermediate and additive layer: it buys tin metal, fatty acids/oils, glycerin, petroleum waxes and basic chemicals, and sells performance additives and intermediates to compounders, formulators, converters and drug manufacturers. Its products are typically low-percentage-by-weight but performance-critical inputs (heat stabilizers in rigid PVC, slip agents in polyolefin film, catalysts in coatings and urethanes, defoamers in food processing). This position confers pricing power when supply is concentrated (evidenced by the 10–25% across-the-board price increase announced by PMC Organometallix in April 2026 [S19]) but exposure to raw-material swings (tin, fatty-acid feedstocks) and to substitution and regulatory risk. ### Customer types and end-markets | End-market | Primary PMC units serving it | Example products | |---|---|---| | Plastics / PVC (building & construction, packaging) | Organometallix, Biogenix, Polymer Products | Organotin heat stabilizers; Armoslip®/Kemamide® slip and anti-block amides; flame-retardant masterbatches | | Coatings, inks, adhesives | Organometallix, Crystal | FASCAT® tin catalysts; CrystalCer® wax emulsions [S20][S25] | | Food processing & fermentation | Crystal, Ouvrie | Food/fermentation defoamers (ex-BASF business) [S2] | | Rubber / tires | PMC Rubber Chemicals (India), Crystal | Accelerators, antioxidants, antiozonants, antiozonant waxes [S21] | | Electronics & wire/cable | Crystal, Polymer Products | Cable-filling compounds, antistatic masterbatches [S5][S21] | | Personal care & consumer products | Biogenix, Ouvrie | Glycerol esters, specialty esters [S12] | | Pharmaceuticals | Isochem, YM-Pharma/PMC Pharmaceuticals India, Copperhead | APIs, intermediates, excipients, NCA/polyamino acids, bulk nitroglycerin [S6][S7][S9] | | Defense | Copperhead | Energetic materials for propellants and munitions (business-level description only) [S8][S31] | | Mining, automotive | Group-wide | Cited in boilerplate [S3][S19] |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1994
NJ, US
Plastiblends

Plastiblends India Limited

Premium
Information Technology

Plastiblends India Limited is one of India's oldest and largest specialist masterbatch producers, manufacturing white, black, colour, additive and filler masterbatches together with polyester masterbatches, conductive compounds and, since 2021, engineering-plastics compounds under the ENGITECH brand. Founded in 1991 by the Kabra family's Kolsite Group (also the promoter of plastics-machinery maker Kabra Extrusiontechnik), the company operates three manufacturing locations at Daman (two units), Roorkee and Palsana (Surat), with roughly 125,000 to 130,000 tonnes per annum of capacity. It exports to more than 60 countries; exports were about 19% of revenue in FY2025 and FY2026. The business is a mid-single-digit-margin converter whose economics are dominated by polymer and pigment input costs. Its distinguishing financial trait is a near debt-free balance sheet with CRISIL A+ rating, but returns on equity have stagnated near 8% as volumes plateaued. Management is repositioning the mix toward black and engineering masterbatches to lift margins. --- ### What the company does Plastiblends manufactures masterbatches: concentrated, pelletised dispersions of pigments (colourants) and/or functional additives in a polymer carrier resin. Plastic processors (film blowers, injection moulders, raffia/woven-sack makers, fibre spinners, pipe extruders, blow moulders) let down a small dosage of masterbatch into virgin or recycled polymer. This imparts colour, opacity, UV stability, anti-static behaviour, slip, anti-block, flame retardancy, antimicrobial or anti-rodent behaviour and similar properties without the processor having to handle raw pigments or additives. The company also makes compounds: fully formulated thermoplastics such as conductive PE/PP/PS compounds and engineering-plastic compounds based on PA6, PA66, PBT, PC, ABS and PP, including blends and alloys. ### The company's own description The company describes itself as India's leading producer and exporter of colour, white, black, additive and filler masterbatches. It says its products serve the plastics and textile industries, that it operates from a Mumbai headquarters with product-development and application units at Daman (two), Roorkee and Palsana, and that annual capacity exceeds 130,000 MT. It cites ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and Global Recycled Standard (4.0) certification, DSIR recognition of its in-house R&D unit, and NABL accreditation of its Daman laboratory. Exchange press releases consistently describe it as the largest player in the masterbatch segment (Source: plastiblends.com "About Us", accessed Oct 2026; Q2 FY2026 press release, 16 Oct 2025). ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | Almost 100% product sales (B2B industrial intermediates). No subscription, licensing or service revenue disclosed. Minor other operating income (export incentives, scrap). | | Pricing mechanism | Cost-plus with partial pass-through. Polymer (crude-linked) is 45-50% of raw-material cost. CRISIL notes major raw-material costs are generally passed on, but intense competition prevents full pass-through of escalations (CRISIL, Jun 2026). | | Order profile | Repeat, short-cycle orders from processors; custom colour matching; no long-term take-or-pay contracts disclosed. | | Channel | Direct sales to processors and OEM-approved moulders, plus dealers/distributors domestically and in export markets (Directors' Report acknowledges "Customers, Dealers"). | | Value-chain position | Mid-stream. Upstream suppliers are petrochemical majors (polymers: PE, PP, PET), pigment producers (TiO2, carbon black, organic pigments) and additive houses. Downstream customers are plastic converters, who in turn supply FMCG packaging, agriculture/irrigation, automotive, appliances, textiles, wire and cable, and pipes. | | Capital intensity | Low-to-moderate. Twin-screw extrusion lines; maintenance plus growth capex of INR 15-20 crore per year guided (CRISIL). | | Working-capital intensity | High. Cash conversion cycle of 137 days in FY2026 (Screener). Gross current asset days (net of cash) rose to 145 in FY2026 from 125 in FY2025 (CRISIL). | ### Customer types and end-markets The website lists nine application verticals: Agriculture; Appliances; Automotive and Transportation; Electrical, Electronics and Telecommunication; Flexible Packaging; Healthcare and Pharmaceutical; Rigid Packaging; Textiles; and Wire and Cable. Trade coverage adds infrastructure and consumer goods. CRISIL identifies the irrigation segment (drip/sprinkler pipes and laterals, largely black masterbatch) as a source of weak demand in FY2026. It also flags a deliberate shift away from the commoditised "Polywhite" (white masterbatch) segment toward black and engineering masterbatches, which serve automotive and white goods. ### Independent characterisation Plastiblends is best understood as a scale-led, low-margin specialty-commodity converter with a franchise in Indian polyolefin masterbatches (white, black and colour for film, raffia and moulding). Three structural facts define its economics: 1. **The value added is a thin slice of a crude-linked bill of materials.** Gross margin is about 25%, EBITDA margin (ex-other income) is 6.7-7.0%, and net margin is 4.3-4.7% (FY2024 to FY2026). 2. **Volume has been stagnant since FY2023.** Revenue moved within INR 768 to 802 crore over FY2023 to FY2026, and CRISIL reports an 8% volume decline in FY2025 offset by 4% realisation gains. 3. **Balance-sheet conservatism.** The company has had no long-term debt since FY2020, carries INR 47 crore of unencumbered cash (Mar 2026), holds mutual-fund and equity investments, and pays a 20-40% dividend. The FY2027 inflection (Q1 FY2027 EBITDA margin of 9.92%) is the first evidence in four years that the mix-shift strategy can lift margins. A meaningful contribution from the Q4 FY2026 inventory gain and the low Q1 FY2026 base means it is not yet proven.

Revenue$0.1B
Employees468
Market CapN/A
Founded1991
United States, North America
Panjin

Panjin Zhongrun High Performance Polymers Co., Ltd.

Premium
Information Technology

Panjin Zhongrun High Performance Polymers was one of China's early private attempts to make polyetheretherketone (PEEK) resin domestically at commercial scale. It was founded in 2009 in the Panjin petrochemical cluster of Liaoning Province. It used the nucleophilic polycondensation route developed at Jilin University and held four synthesis patents covering polysulfone-family resins and copolymerised PEEK. The company built a Phase 1 plant with a nameplate capacity of up to 1,000 t/y and marketed its resin under the CoPEEK brand. By 2012 it was pursuing export markets through an exclusive European distribution agreement with Hamburg-based Bieglo. Its claimed capacity matched that of the eventual domestic leader, Zhongyan. Its commercial traction, however, appears to have been limited: industry directories in 2017 described its operating rate as unknown. By December 2022, a competitor's regulatory filing reported its business licence as revoked. The company is best understood today as a cautionary case study in China's PEEK import-substitution drive, not as an operating competitor. --- ### What the company did Panjin Zhongrun was a resin-synthesis company. It sat in the mid-stream polymerisation step of the PEEK value chain. That step converts aromatic monomers into polymer powder and pellets. The monomers are principally 4,4'-difluorobenzophenone (氟酮, "fluoroketone") and hydroquinone. The reaction uses a carbonate condensing agent in a high-boiling solvent, typically diphenyl sulfone. The company's own published description, as reproduced in a 2017 Aibang directory, emphasised three things: **Four synthesis patents:** covering different methods of producing polysulfone (PSU), polyethersulfone (PES), polyether ether sulfone (PEES), biphenyl polyether ether sulfone (PPSU), and copolymerised PEEK (CoPEEK). - A Phase 1 project of 1,000 t/y of CoPEEK production capacity. - Use of the Jilin University nucleophilic synthesis route. A separate Chinese industry article (China Advanced Materials Industry Expo, undated) stated that the 1,000 t/y CoPEEK unit had entered production and sales. It also claimed that this capacity ensured consistent CoPEEK quality. ### Company's own description from its latest annual report **Not available.** As a private limited company, Panjin Zhongrun publishes no annual report. PRC companies must file an annual report summary with the State Administration for Market Regulation (SAMR) via the National Enterprise Credit Information Publicity System. Revocation of a business licence often follows failure to make these filings. ### Business model and revenue model | Dimension | Characterisation | Evidence quality | |---|---|---| | Revenue model | Product sales (resin powder and pellets); no service, subscription, or licensing revenue identified | Moderate (inferred from product listings and distributor agreement) | | Product vs. service mix | ~100% product (estimated qualitatively; no figures disclosed) | Low | | Licensing | Held 4 synthesis patents; no evidence of out-licensing | Low | | Go-to-market | Direct domestic sales plus third-party distribution abroad (Bieglo, Europe, from 2012) | Moderate | | Pricing posture | Positioned on price competitiveness versus Western incumbents, while arguing that value-in-use, not price, decides customer choice | Moderate (Plasteurope interview with sales director Steven Xu, 2012) | ### Value-chain position | Value-chain stage | Typical players | Panjin Zhongrun role | |---|---|---| | Monomers (fluoroketone, hydroquinone) | Jiangsu Xinhan, Yingkou Xingfu, Zhongxin Fluorine; Eastman/Mitsui (photo-grade hydroquinone) | Buyer (not disclosed which suppliers) | | Polymerisation (resin synthesis) | Victrex, Syensqo/Solvay, Evonik, Zhongyan, Jida Tesu, Pengfulong | Core activity | | Compounding (GF/CF/wear grades) | Resin makers plus compounders | Limited; only unreinforced CoPEEK grades identified | | Stock shapes (rod, sheet, tube) | Ningbo Zheneng, Jiangsu Junhua, Ensinger etc. | Customer segment | | Component fabrication / OEM | Electronics, auto, oil & gas, medical | End markets | ### Customer types and end-markets (independent characterisation) The company did not disclose customer lists. By analogy with Zhongyan's disclosed customer base (December 2022 IPO filing), a Chinese PEEK resin producer of this era would mainly sell to the following groups: 1. **Stock-shape (profile) processors.** These are converters of rod, sheet and tube. They made up about 66–71% of Zhongyan's revenue in 2019–2021. 2. **Component moulders and machinists.** These include makers of seals, bearings, compressor valve plates, wafer carriers and similar parts. 3. **Traders and distributors**, especially for export. End-markets for PEEK at the time included electronics and semiconductors, industrial machinery, oil & gas and energy, automotive, aerospace and medical. Panjin Zhongrun's single verified grade was low-viscosity, unreinforced, rated UL 94 V-0, and also offered as powder. That profile suggests it targeted injection-moulding and coating or compression-moulding applications. Whether it achieved meaningful penetration in any end-market is not publicly disclosed.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2009
Panjin, China
Ozgrowth

Ozgrowth Limited

Premium
Information Technology

### Profiled entity (current) and legacy entity | Field | Current successor entity | Legacy entity (as delisted) | |---|---|---| | Legal name | WAM Capital Limited | Ozgrowth Limited (now A.C.N. 126 450 271, a WAM Capital subsidiary) | | Former names | Not publicly disclosed in sources reviewed | No former names (Market Index); renamed by ACN after acquisition | | ABN / ACN | ABN 34 086 587 395 | ABN 52 126 450 271 / ACN 126 450 271 | | Founding / listing | Listed on ASX August 1999; Geoff Wilson Chairman since March 1999 | Directors first appointed July 2007; company states it was "established in 2008"; first dividend paid August 2008 | | Incorporation jurisdiction | Australia (listed public company, incorporated and domiciled in Australia) | Australia | | Headquarters | Level 26, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000 | Level 18, Alluvion, 58 Mounts Bay Road, Perth WA 6000 | | Exchange / ticker | Australian Securities Exchange / WAM | ASX / OZG (delisted 22 April 2022) | | ISIN / CUSIP | no CUSIP (not US-listed) | no CUSIP | | Fiscal year end | 30 June | 30 June | | Employees | Nil — externally managed; no executives paid by the company (FY2026 Remuneration Report) | Nil — externally managed by Westoz Funds Management | | Investment manager | Wilson Asset Management (International) Pty Limited (100% owned by entities associated with Geoff Wilson) | Westoz Funds Management Pty Ltd (AFSL 285607), 100% owned by Euroz Hartleys Group Limited | | Auditor | Pitcher Partners Sydney (engagement partner Richard King, FY2026) | Not publicly disclosed in sources reviewed | | Share registry | Not stated in sources reviewed | Computershare Investor Services Pty Ltd | | Market capitalisation | $1.7bn at 30 June 2026 (FY2026 Annual Report); approx. $1.34bn implied at ~$1.18 share price on 24 September 2026 (derived: ~1,138m shares × $1.18; share price per Motley Fool, 24 Sep 2026) | Not applicable (delisted); final traded price $0.385 | | Total assets | $1.67bn (30 June 2026 balance sheet); ~$1.4bn "assets" headline in Aug 2026 update | Not applicable | | Website | wilsonassetmanagement.com.au/wam-capital | Former ozgrowth.com.au; legacy page at westozfunds.com.au/ozgrowth-limited | | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Employees of WAM Capital Limited (number) | 0 | 0 | 0 | | Directors (number) | 7 | 6 | 6 | Note: Board count FY2025 reflects Lindsay Mann's resignation on 21 November 2024 (FY2026 Annual Report remuneration tables; 1H FY2024 report lists seven directors). WAM Capital is Australia's longest-established Wilson Asset Management listed investment company and the vehicle into which Ozgrowth Limited was folded in 2022. It offers retail investors a permanent-capital, closed-end exposure to an actively managed portfolio of undervalued small- and mid-cap ASX growth companies, run through two processes: a research-driven, catalyst-based stock-picking engine and a market-driven engine that trades IPOs, placements, block trades, takeovers and LIC discount arbitrage. Its value proposition historically rested on a stable, franked dividend stream (15.5 cents per share every year from FY2020 to FY2026) and a long-run portfolio return of 14.5% per annum since August 1999. That proposition was materially reset in August 2026, when a 10.5% portfolio decline in FY2026 and a depleted profits reserve forced a near-halving of the FY2027 dividend target to 8.0 cents, collapsing the share-price premium to NTA and placing the manager's credibility and fee model under unusual shareholder scrutiny. --- ### Company's own description WAM Capital describes itself as a listed investment company and reporting entity, listed on the ASX in August 1999, that gives investors exposure to an actively managed, diversified portfolio of undervalued growth companies listed on the ASX, with an emphasis on small-to-medium sized businesses (FY2026 Annual Report, p.2). Its stated investment objectives are to deliver a stream of fully franked dividends, provide capital growth, and preserve capital (FY2026 Annual Report, p.25). Its principal activity is making investments in listed companies, and the Directors state no change in that activity occurred or is likely (FY2026 Directors' Report). ### Legacy Ozgrowth description Ozgrowth's objective was to generate positive returns over the medium-to-long term regardless of broader market movements from an actively managed portfolio of small-cap ASX-listed and unlisted investments, and to provide a consistent dividend stream. Holdings typically had a connection to Western Australia through assets, operations or management. Its philosophy emphasised companies with market capitalisations below $50 million, under-researched listed securities and unlisted securities, which a long-horizon LIC structure allowed it to hold (westozfunds.com.au Ozgrowth page). Portfolio risk controls permitted 10–25 stocks, a 20% single-stock cap at acquisition, a 20% cap on stake in any investee, shorts capped at 20% of portfolio, and gross exposure capped at 120% (same source). ### Business and revenue model | Revenue component (AUD M) | FY2025 | FY2026 | |---|---|---| | Net realised and unrealised gains on investments and FX | 313.28 | -193.96 | | Australian sourced dividends | 26.43 | 19.57 | | Interest income | 10.75 | 9.33 | | Trust distributions | 0.73 | 1.71 | | Foreign sourced dividends | 2.63 | 0.97 | | Underwriting fees and other income | 1.87 | 0.39 | | Total revenue from ordinary activities | 355.70 | -161.99 | A LIC does not sell products or services. WAM Capital's "revenue" is investment income: realised and unrealised gains or losses on its equity portfolio plus dividends, distributions, interest and underwriting fees. Its cost base is dominated by fees paid to the external manager. Source: FY2026 Annual Report, Statement of Comprehensive Income and Note 2. Mix characterisation: effectively 100% "investment returns" — no product, subscription or licensing revenue. In FY2026, recurring income (dividends, distributions, interest, fees) was $32.0m, against a $194.0m mark-to-market and realised loss. ### Value-chain position, customers, end-markets WAM Capital sits at the capital-allocation end of the equity value chain: a permanent capital pool that buys and sells ASX-listed equities (and a small number of unlisted pre-IPO stakes, e.g., Firmus Technologies). Its "customers" are its shareholders — overwhelmingly retail and self-managed superannuation fund (SMSF) investors seeking franked income — accessed via the ASX and all major investment platforms (AMP North, BT Panorama, CFS FirstWrap, Netwealth, Macquarie Wrap, Hub24, per the December 2021 merger announcement). The "end-market" is the Australian small/mid-cap listed equity market: at 30 June 2026, 46.1% of the portfolio was in ASX 101–300 companies and 29.4% outside the ASX 300, with zero in the ASX Top 20 (FY2026 Annual Report, p.22). ### Independent characterisation WAM Capital is best understood as a retail-distributed, high-turnover small-cap equity strategy wrapped in a closed-end corporate vehicle whose market value has historically been supported by its dividend policy more than by its NTA. Portfolio turnover is extremely high (FY2026 investment sales of $5.11bn and purchases of $4.93bn against a ~$1.4–1.8bn portfolio, i.e., roughly 3x annual turnover, from the FY2026 cash flow statement), consistent with the market-driven trading sleeve. The economics favour the manager in rising markets (1% base fee plus 20% performance fee with no high-water mark across years beyond the portfolio-decline exclusion) and expose shareholders to NTA erosion when dividends exceed earnings — precisely the dynamic that crystallised in FY2026.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1999
Sydney, Australia
OzAurum

OzAurum Resources Limited

Premium
Information Technology

OzAurum Resources is a Kalgoorlie-based junior gold company moving from explorer to small-scale producer. Its flagship is the 100%-owned Mulgabbie North Gold Project, about 130–135 km north-east of Kalgoorlie on the Relief Shear and about 2 km from Northern Star's Carosue Dam operation. The project holds a JORC (2012) Mineral Resource of 11.6 Mt at 0.70 g/t Au for about 260,000 oz, of which 64% is Measured and Indicated. The company's strategy is a capital-light, owner-operated, staged heap-leach development: **Stage 1:** is a metallurgical-trial open pit at James feeding a two-cell heap, using a second-hand agglomeration plant acquired in January 2026. It holds environmental and mining approvals. **Stages 2 and 3:** are planned as a larger operation of up to 32 cells / about 2 Mt heap capacity, centred on a shallow, high-grade paleochannel. Secondary assets are the Patricia Gold Project (WA) and early-stage niobium/REE ground in Brazil's Alto Paranaíba province. ASX-listed Forrestania Resources holds 19.9%, and founder-CEO Andrew Pumphrey holds about 14.9%. --- ### Company's own description In its FY2026 Annual Report, the company describes its principal activity as mineral exploration for gold, lithium and rare earth elements, with no significant change in the nature of those activities during the year [S1]. Its stated business model is to create value by discovering economic quantities of mineralisation and resources. It does this by: - identifying projects that fit its strategy; - designing project-specific exploration programs to quantify mineral potential; and - continually assessing results against other projects, funding options and opportunities [S1]. The FY2026 Directors' Report states that the primary focus is development of Mulgabbie North, while exploration continues elsewhere and other potential projects are reviewed [S1]. ### Independent characterisation | Dimension | Characterisation | |---|---| | Current revenue | Nil operating revenue. Only interest income (A$35,302 in FY2026) and a one-off non-cash gain on settling a liability (A$114,800) [S1] | | Intended revenue model | Sale of gold doré from an owner-operated open-pit and heap-leach operation (commodity product sales, price-taker) | | Product / service / subscription / licensing mix | 100% prospective commodity product; no service, subscription or licensing revenue | | Value chain position | Upstream: exploration → resource definition → mining → heap-leach processing to doré. Refining and marketing would be outsourced (not yet contracted) | | Customer types | Prospective: bullion refiners (e.g., Perth Mint-type refiners); no offtake disclosed | | End-markets | Global gold market (investment, central bank, jewellery demand) via refined bullion; secondary optionality in niobium/REE (steel alloying, magnets) through Brazil exploration | | Operating model | Owner-operator. Civil works are done in-house. Plant refurbishment is outsourced to Polaris Engineering Services. Drilling is contracted (VM Drilling, partly paid in shares). Metallurgical testing is done at ALS Balcatta plus an in-house percolation laboratory at Coolgardie [S1], [S17] | OzAurum is best described as a micro-cap, pre-revenue, single-asset gold developer. During FY2026 it changed character from a pure explorer to an early-stage builder. The evidence: **New expense line:** The FY2026 income statement shows a "development costs" line (A$221,063) for the first time [S1]. **Fixed assets ballooned:** Property, plant and equipment rose from A$0.41M to A$2.23M, driven by the acquisition and refurbishment of a heap-leach agglomeration plant [S1]. **Approvals in hand:** The company holds Stage 1 environmental approval under Western Australia's Small Mining Operation Policy and Mining Operator Notification approval to begin open-pit mining [S1]. **Remaining permits:** At the date of the annual report, a Dangerous Goods Licence application had been lodged. A Department of Health Poisons Permit (needed for cyanide) is still to be sought [S1]. **Business model / revenue model.** **Economic logic of the strategy.** **Why heap leach:** The resource is low-grade overall (0.70 g/t), which would struggle to justify a standalone carbon-in-leach (CIL) mill at this scale. The Stage 1 pit and the paleochannel, however, contain shallow higher-grade zones (e.g., James grade-control intervals of 2–6 g/t; paleochannel intervals commonly 3–8 g/t over 2–8 m) [S1]. Heap leaching avoids the A$100M+ capital typical of a new mill. **Low-cost plant:** The company bought a second-hand plant with a long operating history (Marvel Loch, Nifty, Bullabulling) to cut capital intensity further [S1]. **Gold price tailwind:** The company says record A$ gold prices (about A$7,200/oz cited in January 2026) materially improve the investment case [S7].

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1990
West Kalgoorlie, Australia
Oxley

Oxley Bridge Acquisition Limited

Premium
Information Technology

Oxley Bridge Acquisition Limited is a $253 million Nasdaq-listed blank-check company. It was formed in August 2024 and closed its IPO in June 2025. Its sponsor is controlled by Jonathan Hou Pu Lin, co-founder and CIO of L2 Capital. Its stated mandate is to merge with a global consumer or technology business that has disruptive growth potential and can benefit from expanding in Asia. Mainland China, Hong Kong and Macau are explicitly excluded. It initially targets enterprise values of about $500 million to $1.0 billion. The management bench combines public-market investors, private-equity and venture investors, and operating "enterprise builders" across Canada, Hong Kong, Singapore and the Philippines. As of 30 June 2026 it held $262.8 million in trust, or $10.39 per public share, in Treasury money-market funds. It had no definitive agreement and about 12 months left to close a deal. Its investment case therefore rests on sponsor deal-sourcing, with a floor near trust value. --- **Company's own description (10-K FY2025).** The company describes itself as a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. It may pursue a target in any industry. It is searching globally for a target in the consumer and technology sectors with disruptive growth potential through technology that can benefit from operations in Asia, excluding China (defined to include Hong Kong and Macau). It has generated no operating revenue and does not expect to until it completes a business combination. **Business model.** The economics are those of a standard US-listed SPAC: **Revenue model mix.** Product 0%, service 0%, subscription 0%, licensing 0%. The only income is non-operating interest and dividends on trust and cash balances. **Value chain position and customers.** None in the conventional sense. Functionally, OBA is a capital-markets intermediary. It offers a private company an alternative route to a US listing and access to the trust cash, subject to redemptions. Its "customers" are prospective targets and its investors. **Independent characterization.** OBA is a mid-sized, Cantor-led SPAC with a cross-border Asia thesis. The China exclusion is a deliberate regulatory de-risking choice, given US scrutiny of China-linked listings. It narrows the target universe to Southeast Asia, India, Japan, Korea, Australia and global companies with Asian expansion plans. The stated enterprise-value band of $500M–$1.0B is about 2–4× the trust. A completed deal would therefore likely need PIPE, forward-purchase or non-redemption financing if redemptions are material.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2024
Vancouver, Canada
Oventus

Oventus Medical Limited

Premium
Information Technology

Oventus Medical was a Brisbane-based medical device company that tried to change oral appliance therapy for obstructive sleep apnoea (OSA). Its O2Vent devices combined a mandibular advancement splint with a built-in airway channel. The channel was designed to bypass obstructions at the nose, soft palate and tongue, a patented feature that set it apart from conventional mandibular advancement devices. The product line moved from 3D-printed titanium (O2Vent Mono/T) to 3D-printed medical-grade nylon (O2Vent Optima), with an ExVent valve accessory for harder cases. Commercially, Oventus targeted CPAP-intolerant patients in Australia, the US and Canada. It used a "lab-in-lab" model inside sleep clinics, and later direct-to-consumer telehealth channels. It never moved beyond micro-scale revenue, peaking at about A$1.1M in FY2021, while losing roughly A$6–10M a year. It entered voluntary administration in June 2022, and its IP was sold to a Canadian distributor. --- **What the company did.** Oventus designed, manufactured (or contract-manufactured) and sold custom-fitted oral appliances for OSA and snoring. Every device was made to fit an individual patient's dentition from a scan or impression, then 3D-printed. The distinguishing feature was an integrated airway running through the front of the appliance. The company said this allowed breathing even when the nose was blocked, while the appliance held the jaw forward like a standard mandibular advancement splint (MAS). The company's late-stage descriptions (as summarised by MarketBeat and roic.ai) say that O2Vent Optima addressed the whole upper airway. Its built-in channel bypassed obstruction from the nose, soft palate and tongue, while keeping an oral seal and a stable jaw position. ExVent was a valve accessory that fitted into the airway to regulate exhalation for harder-to-treat cases. **Company's own description (latest available).** Earlier ASX disclosures described Oventus as an Australia-based medical device company commercialising a suite of oral appliances for sleep apnoea and snoring. They also described its principal activities as commercialising and distributing the O2Vent in Australia and developing a product pipeline for segments of the snoring and sleep apnoea market. By 2020, the company described itself as an "obstructive sleep apnoea treatment innovator" marketing products under the O2Vent Optima brand (SmallCaps, 2020). **Business model evolution (independent characterisation).** The model went through three phases: 1. **Dentist channel (2016–2018).** Devices were sold to dentists in Australia and, after the January 2017 US pilot launch, in the US. A US subsidiary (Oventus Medical USA, Delaware) and an FDA-registered US dental lab contract manufacturer supported this (ASX release, 18 Jan 2017). 2. **"Lab-in-lab" sleep-clinic model (2019–2021).** Oventus placed its dental sleep service inside sleep physician groups and durable medical equipment (DME) providers. The aim was to capture CPAP-intolerant patients at the point of diagnosis rather than relying on referrals to dentists. Partners included Aeroflow Healthcare, Delaware Sleep Disorder Centres, Reliable Respiratory, Careica Health, Specialized Sleep, PEAKsleep, Tri Hospital Sleep and Ontario Sleep Care. At one point 36 sites were contracted, with 14 live by early 2020 (HME News, April 2020). 3. **Direct-to-consumer and telehealth (2021–2022).** Patients were sold to through o2vent.com, gopapfree.com and awakexpress.com, with a "virtual patient journey" supported by telehealth (HME News, Aug 2021 and Feb 2022). **Revenue model mix.** Revenue was almost entirely product-based: device sales per patient and consumables (ExVent resupply packs, connector bands). There was some service revenue embedded in lab-in-lab arrangements, but a split between product, service and subscription was not publicly disclosed. ExVent "Annual Resupply Packs" gave a nascent recurring consumable stream (product list in the Nov 2022 Canadian distribution agreement). **Value chain position.** Oventus owned the IP and product design. It ran a 3D-printing manufacturing operation in Australia (Oventus Manufacturing Pty Ltd) and used a US contract dental lab. Later it held the clinical delivery model (lab-in-lab) and patient acquisition (DTC). In effect it was vertically integrated from design to patient, which is capital-intensive for a company with sub-A$1.1M revenue. **Customer types.** These were dentists (dental sleep medicine practitioners), sleep physician groups and sleep labs, DMEs and home medical equipment providers (e.g., Aeroflow), Medicare and commercial payers in the US (through PDAC coding), and consumers directly. **End-markets.** The end-markets were the treatment of OSA and snoring, specifically the CPAP-intolerant and CPAP-non-adherent segment. At IPO the company estimated the global sleep apnoea therapeutic device market at US$3.5B, growing 7.4% a year (Business News Australia, June 2016).

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2013
Indooroopilly, Australia
Ovanti

Ovanti Ltd

Premium
Information Technology

Ovanti Limited is a micro-cap ASX-listed fintech whose only revenue-producing operation is iSentric. Through its Malaysian and Indonesian subsidiaries, iSentric provides mobile-banking messaging, customer authentication (one-time-password/SMS), digital payments and transaction-processing services to banks, telcos and corporates. Ovanti also holds a 21% equity-accounted stake in I-Destinasi Sdn Bhd (IDSB), a Malaysian payroll-deduction consumer-finance agent. That stake is carried at A$14.3 million, which is most of the group's balance sheet. Between 2021 and 2026 the company pursued successive high-cost growth narratives: Malaysian buy-now-pay-later (myIOU), a US BNPL launch (Flote/Ovanti US), a Nasdaq SPAC, a "financial Super App", and prediction markets (Ominari, Yuno.trade). Each ended in write-offs or termination. On 20 August 2026 the board exited BNPL globally after Ovanti US entered Chapter 7. The company now positions itself as a Southeast/Central Asian "programmable financial infrastructure" provider built on iSentric. It has negligible cash, a A$1–2 million market value, and serious going-concern exposure. --- ### Company's own description Ovanti's boilerplate (ASX releases 2025–2026, FY2023 directors' report) describes the company as follows: - It provides fintech and digital commerce software solutions and services. These let institutional customers securely authenticate end users and process banking, purchase and payment transactions. - Its core platform connects customer communities to end users on any mobile device and integrates mobile technology into clients' existing products. - Historically it described three divisions (Mobile Banking, Digital Payments and Digital Services) serving the "top 20 banks in Malaysia" plus telcos and corporates in Malaysia and Indonesia. - It works with telecom network providers to deliver mobile over-the-top (OTT) services that use their subscriber bases. After the August 2026 strategic review, the company describes iSentric as delivering mobile banking, authentication, digital payments, transaction processing and enterprise technology services to banking, telecommunications and corporate clients in Asia. iSentric is now the sole commercial focus (ASX "OVT Exits BNPL and Cost Cuts", 20 Aug 2026, via FNN/ShareCafe). ### Independent characterisation In economic substance, Ovanti is three things: 1. **A small Malaysian A2P (application-to-person) messaging and authentication processor (iSentric).** - It earns per-transaction or per-message service fees from banks and telcos. - Gross margins are thin: 10.5% in FY2025 and 4.0% in FY2026 on statutory figures. This is consistent with telco-carriage pass-through costs (SMS termination fees) dominating cost of sales. - All recognised revenue is "mobile services", recognised over time, 100% in Malaysia (FY2024–FY2026 Appendix 4E, Note 1). 2. **A passive minority investor in IDSB.** - IDSB is a specialist outsourced agent for Malaysian banks. It originates and services instalment-based consumer credit to civil servants via Accountant-General salary-deduction codes. - The stake produced equity-accounted profit of A$1.79m (FY2025) and A$1.44m (FY2026), larger than iSentric's gross profit in both years. 3. **A listed shell for capital-intensive new ventures.** - The ventures have been funded almost entirely by highly dilutive equity: A$16.5m gross raised in FY2025 and A$17.6m in FY2026. - Spending went mainly on compliance and professional fees (A$8.66m in FY2026) and product development (A$5.98m in FY2026), not on revenue-generating activity. ### Business and revenue model mix (FY2026) | Revenue model | Share of FY2026 statutory revenue | Comment | |---|---|---| | Services (transaction/message processing, mobile services) | 100% | A$2.345m, Malaysia, "services transferred over time" | | Product sales | 0% | None reported | | Subscription | Not separately disclosed | Some iSentric contracts may be platform/maintenance-based. The FY2023 accounting policy lists support/maintenance and software licensing revenue streams, but these are not split out | | Licensing | 0% recognised | Prediction-market licensing/processing arrangements (Yuno.trade) produced no disclosed revenue in FY2026 | | Equity-accounted income (below revenue) | n/a | Share of IDSB profit A$1.442m, reported in other income | ### Value-chain position, customers and end-markets **Value-chain position:** a middleware/aggregator between telecom carriers (message termination) and financial institutions (authentication and transaction alerts). Ovanti owns neither the carrier network nor the bank customer relationship's balance sheet. **Customer types:** - Malaysian commercial banks. The company has cited a "Top 3 Malaysian bank" contract (2024 ASX release) and, in the June 2026 Yuno.trade announcement, a relationship with Standard Chartered. - Insurers, telcos and corporates. **End-markets:** Malaysian (and historically Indonesian) digital banking and payments security; consumer finance (via IDSB); aspirational prediction markets and digital-asset infrastructure in Southeast/Central Asia (Aug 2026 strategy).

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2000
Melbourne, Australia
OttoEnergy

Otto Energy Ltd.

Premium
Information Technology

Otto Energy is a micro-cap, debt-free, non-operating oil and gas producer listed on the ASX. Its entire portfolio is on the US Gulf Coast: a 50% WI in the South Marsh Island 71 (SM 71) shelf oil field operated by Byron Energy, a 37.5% WI in the Lightning gas-condensate field in Matagorda County, Texas, operated by Hilcorp, a 16.7% WI in the Green Canyon 21 (GC 21) "Bulleit" deepwater well operated by Talos Energy, and 30% WIs in the Mosquito Bay West and Oyster Bayou South wells in Louisiana state waters operated by Castex. FY26 production averaged 1,266 boe/d (54% liquids) and generated US$15.2M of net operating revenue and US$4.1M of net profit. Since 2023 the company has functioned as a harvest-and-return vehicle. It has no exploration spend, has cut G&A repeatedly, paid an A$38.4M distribution in June 2025, and launched a sale process for its Gulf of America assets in June 2026. Its market value trades close to its net cash, and German investor Otto Happel's Molton Holdings controls about 48%. --- **Company's own description.** In its 2026 quarterly reports, Otto describes itself as an ASX-listed oil and gas exploration and production company focused on the US Gulf Coast. It lists production from: - SM 71 and GC 21 in the Gulf of America (the US federal name for the Gulf of Mexico since 2025); - the Mosquito Bay West and Oyster Bayou South fields in Louisiana state waters; - the Lightning assets onshore Texas. The company states that cash flow from these producing assets underpins its strategy and financial stability (Quarterly Activity Report, Jun 2026). **Independent characterisation.** Otto is a pure non-operated royalty-like working-interest holder. - It operates none of its assets. It pays its share of lease operating, gathering and capital costs through joint interest billings (JIBs) and receives its NRI share of hydrocarbon sales. - Its value chain position is upstream only. It has no midstream, refining or marketing operations. - Its revenue model is 100% commodity product sales: crude oil, natural gas and NGLs. It has no service, subscription or licensing revenue. - Customers are the purchasers arranged through operators: Gulf Coast crude purchasers and refiners (oil is priced off LLS and WTI) and gas and NGL off-takers on Texas and Louisiana pipeline systems. Named purchasers are n/d. - End-markets are the US Gulf Coast refining market for crude and the US Henry Hub-linked gas market. Mix by product, FY26 (WI basis): Source: FY26 Financial Results. NGL revenue is derived as total less oil less gas. Net operating revenue (after royalties) was US$15.2M in FY26 against US$19.45M of WI revenue. The gap reflects lessor royalties, which is the difference between WI and NRI. Profitability depends almost entirely on oil prices and on operators keeping wells online. In FY26 there was no exploration or capital expenditure.

RevenueN/A
Employees1
Market CapN/A
Founded2004
United States, North America

Page 219 of 482

1…218219220…482

Page 219 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo